Khói phẫu thuật: Nguy cơ và giải pháp hút lọc khói trong phòng mổ

How is surgical smoke generated?
When electrosurgical units, lasers, or heat-generating devices interact with tissue, the heat at the intervention site can destroy cells and produce a mixture of vapors, gases, and suspended particulate matter. This mixture is commonly referred to as surgical smoke, surgical plume, or electrosurgical smoke.
Consequently, surgical smoke is not merely "smoke" in the conventional sense. Its composition depends on the tissue type, the energy device used, the power settings, and the specifics of the procedure.
NIOSH notes that surgical smoke can contain chemical gases and vapors, bioaerosols, cellular material, and biological components. Detected compounds include benzene, hydrogen cyanide, and formaldehyde. OSHA also identifies carbon monoxide, polycyclic aromatic hydrocarbons, and various gases present at trace levels within the surgical plume.
This explains why the management of surgical smoke should not be viewed solely as a matter of eliminating unpleasant odors.
________________________________________
How can surgical smoke affect operating room personnel?
Particular attention must be paid not only to patients but also to surgeons, nurses, anesthesiologists, technicians, and other staff who regularly work in the operating room.
A critical factor is the nature of repeated exposure. While a single surgery may generate smoke for only a limited duration, healthcare personnel may participate in multiple surgeries daily and continue working in this environment for years.
Respiratory irritation and related symptoms
OSHA notes that surgical plume can cause upper respiratory tract irritation, particularly with high-level exposure. Professional literature from AORN also documents symptoms experienced by individuals exposed to surgical smoke, such as headaches, throat irritation, and dizziness. NIOSH therefore considers the inhalation of surgical smoke a potential risk for both the surgical team and the patient.
Chemical and biological constituents
Another issue is that surgical smoke is not a homogeneous mixture.
Studies have detected various chemical substances and biological materials within the surgical plume. NIOSH cites gases, toxic vapors, bioaerosols, and cellular material; OSHA also notes that the smoke has shown mutagenic potential in *in vitro* studies.
However, the evidence must be interpreted with caution.
The detection of biological materials or potentially harmful substances in the smoke does not mean that every exposure leads to disease; OSHA notes that there is no documented evidence of infectious disease transmission via surgical smoke in clinical settings, although the potential for generating infectious viral particles in certain situations has been a concern.
For this reason, the appropriate approach is not to incite undue alarm, but rather to reduce preventable exposure.
________________________________________
In laparoscopic surgery, the issue also involves surgical visibility.
In laparoscopic abdominal surgery, smoke is generated within a closed surgical cavity where pneumoperitoneum is maintained.
When electrosurgery is used within the abdomen, smoke can accumulate and impair the clarity of the laparoscopic image. This creates a practical issue beyond mere exposure:
the smoke can obstruct the surgeon's view.
NIOSH has long recognized that high concentrations of surgical smoke can impair surgeon visibility; AORN guidelines also identify smoke evacuation and filtration systems in minimally invasive surgery as appropriate control measures when the generation of surgical smoke is anticipated. Therefore, smoke management during endoscopy has two parallel objectives:
maintaining the surgical field of view and limiting the release of unfiltered smoke into the operating room environment.
________________________________________
Why do operating room ventilation and face masks fail to fully resolve the issue?
A key principle of occupational hazard control is:
Controlling contaminants as close to the source as possible.
While general operating room ventilation plays a vital role in air quality, AORN emphasizes that it is not a substitute for smoke evacuation and filtration at the source.
Similarly, respiratory protection may serve a supplementary role in appropriate situations but should not be viewed as a substitute for effective source-based smoke control. This aligns with the "hierarchy of controls" approach emphasized in AORN’s guidelines on surgical smoke safety.

What role does smoke extraction and filtration at the source play?
NIOSH recommends combining general ventilation with local exhaust ventilation to control smoke generated by lasers and electrosurgical equipment. OSHA also cites local smoke extraction and filtered evacuation systems as measures for controlling exposure.
AORN currently emphasizes source capture and filtration as the preferred method in surgical smoke control strategies.
In open surgery, this is typically achieved by positioning a suction tip near the point of smoke generation.
In laparoscopic surgery, the challenge differs: smoke is generated within the abdominal cavity. Consequently, one applicable method involves routing the smoke-laden gas from the pneumoperitoneum through a filtration system before it is exhausted.
This is where smoke filters connected to the trocar come into play.

LiNA LapGuard™ and the role of smoke filtration in laparoscopic surgery

The LiNA LapGuard™ is designed as a laparoscopic smoke filter.
According to the manufacturer's official information, the device utilizes an ULPA filter combined with activated carbon to facilitate the evacuation and filtration of electrosurgical smoke during laparoscopic procedures.
A notable feature of the LapGuard’s design is its simplicity.
The device connects to the trocar's gas port via a Luer lock. During extensive use of electrosurgery, the roller clamp can be adjusted to maintain appropriate gas flow. This mechanism is described by LiNA in its product documentation.
This enables the LapGuard to function as follows:
Abdominal cavity → gas containing surgical smoke → trocar gas port → LapGuard → filtration → gas vented externally
As opposed to:
Abdominal cavity → opening the gas port → smoke released directly into the operating room.
________________________________________
The ULPA filter and activated carbon serve distinct functions.
The technical structure warrants explanation as well.
The ULPA filter is designed to capture very fine particles within the gas stream, while the activated carbon helps address odor-related components.
LiNA states that the LapGuard has been tested against aerosolized viruses with diameters of 25–27 nm, achieving a filtration efficiency of 99.999968% under the company's test conditions.
However, this figure must be interpreted correctly:
it represents filtration efficiency data under test conditions, not evidence that the device prevents a corresponding percentage of infections or clinical adverse events.
This distinction is particularly important in a medical context.
________________________________________
The LapGuard™ should not be viewed as a substitute for a comprehensive smoke control program.
This is a point that needs to be clarified.
The LapGuard™ should not be described as a product that "eliminates all risks associated with surgical smoke." Surgical smoke control requires a holistic approach that considers the type of procedure, anticipated smoke volume, energy devices used, operating room ventilation, smoke evacuation and filtration systems, and facility-specific safety protocols.
AORN currently approaches surgical smoke management as a comprehensive safety program encompassing risk assessment, procedure-specific planning, smoke evacuation and filtration, respiratory protection (when necessary), staff training, and practice quality assessment.
Within this strategy, the specific role of LapGuard™ is:
to control and filter the smoke-laden gas stream directly at the trocar exhaust port during laparoscopic surgery.
This places the product in a scientifically sound context, rather than simply describing it as a "smoke evacuator."
________________________________________
A small change can impact the operating room environment
Surgical smoke is a common byproduct of energy-based devices, but its familiarity does not mean it should be taken lightly.
Documentation from NIOSH, OSHA, and AORN indicates that surgical smoke is an issue requiring management in the surgical environment. Source control and smoke filtration are key components of exposure reduction strategies.
In laparoscopic surgery, where smoke can accumulate within the pneumoperitoneum and impair visibility, controlling the gas flow exiting the trocar has direct practical implications for the surgical procedure.
Trocar-based smoke filtration devices, such as LiNA LapGuard™, offer a relatively simple solution for routing smoke-laden gas through a filter before it is released into the operating room environment. According to LiNA’s documentation, LapGuard utilizes ULPA filtration combined with activated carbon and connects directly to the trocar's gas port. Therefore, the value of smoke control lies not merely in adding a device to the operating room, but in a broader principle:
Surgical smoke is a source of exposure that can be controlled. With the right solution in place, reducing the amount of unfiltered smoke released into the operating room environment should be considered an integral part of safe surgical practice.
Reference Materials
Key sources for this article include guidelines and documentation from NIOSH/CDC (*Control of Smoke From Laser/Electric Surgical Procedures*), OSHA (*Laser/Electrosurgery Plume*), and AORN (*Guideline for Surgical Smoke Safety*), as well as official technical information from LiNA Medical regarding LiNA LapGuard™.

{"id" :3947203, "type_config_slider" :{"config_slider":{"spaceBetween":10,"autoplay":true,"lazy":true,"slidesPerView":3,"loop":true,"allowTouchMove":true,"speed":300,"slidesPerColumn":1,"pagination":[],"navigation":{"nextEl":".swiper-button-next","prevEl":".swiper-button-prev"},"effect":"slide","cubeEffect":{"shadow":true,"slideShadows":true,"shadowOffset":20,"shadowScale":0.939999999999999946709294817992486059665679931640625},"coverflowEffect":{"ronate":50,"stretch":0,"depth":100,"modifier":1,"slideShadows":true},"flipEffect":{"rotate":30,"slideShadows":false},"fadeEffect":{"crossFade":true}},"config_slider_thumb":{"slidesPerView":4,"spaceBetween":10,"speed":300,"freeMode":true,"allowTouchMove":false},"is_used_thumb":false,"is_used_pagi":false,"is_used_nav":true,"is_used_nav_thumb":true,"is_used_pagi_thumb":true,"auto_calc_height_item":0,"icon":{"nextEl":"fas fa-chevron-right","prevEl":"fas fa-chevron-left"},"responsive":{"768px":[],"640px":{"icon":{"nextEl":"fas fa-chevron-right","prevEl":"fas fa-chevron-left"},"config_slider":{"slidesPerView":2}},"480px":{"icon":{"nextEl":"fas fa-chevron-right","prevEl":"fas fa-chevron-left"},"config_slider_thumb":{"slidesPerView":4,"spaceBetween":10,"speed":300,"freeMode":true,"allowTouchMove":false},"config_slider":{"slidesPerView":1,"spaceBetween":10,"autoplay":true,"lazy":true,"loop":true,"allowTouchMove":true,"speed":300,"slidesPerColumn":1,"pagination":[],"navigation":{"nextEl":".swiper-button-next","prevEl":".swiper-button-prev"},"effect":"slide","cubeEffect":{"shadow":true,"slideShadows":true,"shadowOffset":20,"shadowScale":0.939999999999999946709294817992486059665679931640625},"coverflowEffect":{"ronate":50,"stretch":0,"depth":100,"modifier":1,"slideShadows":true},"flipEffect":{"rotate":30,"slideShadows":false},"fadeEffect":{"crossFade":true}}},"320px":{"icon":{"nextEl":"fas fa-chevron-right","prevEl":"fas fa-chevron-left"},"config_slider":{"slidesPerView":1}}}}}

{"id":753594,"name":"Surgical smoke in laparoscopic surgery: Exposure risks and the role of at-source smoke control","desc":"In the operating room, the development of electrosurgical units, lasers, and energy-based devices has yielded significant benefits regarding hemostasis, tissue dissection, and surgical efficiency. However, when thermal energy interacts with tissue, a nearly unavoidable byproduct is generated: surgical smoke (or surgical plume).<\/p>Surgical smoke is sometimes viewed merely as an issue concerning odor or visibility within the surgical field. In reality, numerous professional organizations and occupational safety agencies regard the management of surgical smoke as a matter of operating room environmental safety and occupational exposure. NIOSH has issued recommendations for controlling smoke from lasers and electrosurgical devices since 1996, and AORN continues to emphasize smoke capture and filtration at the source as a critical control measure<\/p>","content":"How is surgical smoke generated? When electrosurgical units, lasers, or heat-generating devices interact with tissue, the heat at the intervention site can destroy cells and produce a mixture of vapors, gases, and suspended particulate matter. This mixture is commonly referred to as surgical smoke, surgical plume, or electrosurgical smoke. Consequently, surgical smoke is not merely \"smoke\" in the conventional sense. Its composition depends on the tissue type, the energy device used, the power settings, and the specifics of the procedure. NIOSH notes that surgical smoke can contain chemical gases and vapors, bioaerosols, cellular material, and biological components. Detected compounds include benzene, hydrogen cyanide, and formaldehyde. OSHA also identifies carbon monoxide, polycyclic aromatic hydrocarbons, and various gases present at trace levels within the surgical plume. This explains why the management of surgical smoke should not be viewed solely as a matter of eliminating unpleasant odors. ________________________________________ How can surgical smoke affect operating room personnel? Particular attention must be paid not only to patients but also to surgeons, nurses, anesthesiologists, technicians, and other staff who regularly work in the operating room. A critical factor is the nature of repeated exposure. While a single surgery may generate smoke for only a limited duration, healthcare personnel may participate in multiple surgeries daily and continue working in this environment for years. Respiratory irritation and related symptoms OSHA notes that surgical plume can cause upper respiratory tract irritation, particularly with high-level exposure. Professional literature from AORN also documents symptoms experienced by individuals exposed to surgical smoke, such as headaches, throat irritation, and dizziness. NIOSH therefore considers the inhalation of surgical smoke a potential risk for both the surgical team and the patient. Chemical and biological constituents Another issue is that surgical smoke is not a homogeneous mixture. Studies have detected various chemical substances and biological materials within the surgical plume. NIOSH cites gases, toxic vapors, bioaerosols, and cellular material; OSHA also notes that the smoke has shown mutagenic potential in *in vitro* studies. However, the evidence must be interpreted with caution. The detection of biological materials or potentially harmful substances in the smoke does not mean that every exposure leads to disease; OSHA notes that there is no documented evidence of infectious disease transmission via surgical smoke in clinical settings, although the potential for generating infectious viral particles in certain situations has been a concern. For this reason, the appropriate approach is not to incite undue alarm, but rather to reduce preventable exposure. ________________________________________ In laparoscopic surgery, the issue also involves surgical visibility. In laparoscopic abdominal surgery, smoke is generated within a closed surgical cavity where pneumoperitoneum is maintained. When electrosurgery is used within the abdomen, smoke can accumulate and impair the clarity of the laparoscopic image. This creates a practical issue beyond mere exposure: the smoke can obstruct the surgeon's view. NIOSH has long recognized that high concentrations of surgical smoke can impair surgeon visibility; AORN guidelines also identify smoke evacuation and filtration systems in minimally invasive surgery as appropriate control measures when the generation of surgical smoke is anticipated. Therefore, smoke management during endoscopy has two parallel objectives: maintaining the surgical field of view and limiting the release of unfiltered smoke into the operating room environment. ________________________________________ Why do operating room ventilation and face masks fail to fully resolve the issue? A key principle of occupational hazard control is: Controlling contaminants as close to the source as possible. While general operating room ventilation plays a vital role in air quality, AORN emphasizes that it is not a substitute for smoke evacuation and filtration at the source. Similarly, respiratory protection may serve a supplementary role in appropriate situations but should not be viewed as a substitute for effective source-based smoke control. This aligns with the \"hierarchy of controls\" approach emphasized in AORN’s guidelines on surgical smoke safety.<\/p>What role does smoke extraction and filtration at the source play? NIOSH recommends combining general ventilation with local exhaust ventilation to control smoke generated by lasers and electrosurgical equipment. OSHA also cites local smoke extraction and filtered evacuation systems as measures for controlling exposure. AORN currently emphasizes source capture and filtration as the preferred method in surgical smoke control strategies. In open surgery, this is typically achieved by positioning a suction tip near the point of smoke generation. In laparoscopic surgery, the challenge differs: smoke is generated within the abdominal cavity. Consequently, one applicable method involves routing the smoke-laden gas from the pneumoperitoneum through a filtration system before it is exhausted. This is where smoke filters connected to the trocar come into play.<\/p>LiNA LapGuard™ and the role of smoke filtration in laparoscopic surgery<\/strong><\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(133).png\"><\/figure>The LiNA LapGuard™ is designed as a laparoscopic smoke filter. According to the manufacturer's official information, the device utilizes an ULPA filter combined with activated carbon to facilitate the evacuation and filtration of electrosurgical smoke during laparoscopic procedures. A notable feature of the LapGuard’s design is its simplicity. The device connects to the trocar's gas port via a Luer lock. During extensive use of electrosurgery, the roller clamp can be adjusted to maintain appropriate gas flow. This mechanism is described by LiNA in its product documentation. This enables the LapGuard to function as follows: Abdominal cavity → gas containing surgical smoke → trocar gas port → LapGuard → filtration → gas vented externally As opposed to: Abdominal cavity → opening the gas port → smoke released directly into the operating room. ________________________________________ The ULPA filter and activated carbon serve distinct functions. The technical structure warrants explanation as well. The ULPA filter is designed to capture very fine particles within the gas stream, while the activated carbon helps address odor-related components. LiNA states that the LapGuard has been tested against aerosolized viruses with diameters of 25–27 nm, achieving a filtration efficiency of 99.999968% under the company's test conditions. However, this figure must be interpreted correctly: it represents filtration efficiency data under test conditions, not evidence that the device prevents a corresponding percentage of infections or clinical adverse events. This distinction is particularly important in a medical context. ________________________________________ The LapGuard™ should not be viewed as a substitute for a comprehensive smoke control program. This is a point that needs to be clarified. The LapGuard™ should not be described as a product that \"eliminates all risks associated with surgical smoke.\" Surgical smoke control requires a holistic approach that considers the type of procedure, anticipated smoke volume, energy devices used, operating room ventilation, smoke evacuation and filtration systems, and facility-specific safety protocols. AORN currently approaches surgical smoke management as a comprehensive safety program encompassing risk assessment, procedure-specific planning, smoke evacuation and filtration, respiratory protection (when necessary), staff training, and practice quality assessment. Within this strategy, the specific role of LapGuard™ is: to control and filter the smoke-laden gas stream directly at the trocar exhaust port during laparoscopic surgery. This places the product in a scientifically sound context, rather than simply describing it as a \"smoke evacuator.\" ________________________________________ A small change can impact the operating room environment Surgical smoke is a common byproduct of energy-based devices, but its familiarity does not mean it should be taken lightly. Documentation from NIOSH, OSHA, and AORN indicates that surgical smoke is an issue requiring management in the surgical environment. Source control and smoke filtration are key components of exposure reduction strategies. In laparoscopic surgery, where smoke can accumulate within the pneumoperitoneum and impair visibility, controlling the gas flow exiting the trocar has direct practical implications for the surgical procedure. Trocar-based smoke filtration devices, such as LiNA LapGuard™, offer a relatively simple solution for routing smoke-laden gas through a filter before it is released into the operating room environment. According to LiNA’s documentation, LapGuard utilizes ULPA filtration combined with activated carbon and connects directly to the trocar's gas port. Therefore, the value of smoke control lies not merely in adding a device to the operating room, but in a broader principle: Surgical smoke is a source of exposure that can be controlled. With the right solution in place, reducing the amount of unfiltered smoke released into the operating room environment should be considered an integral part of safe surgical practice. Reference Materials Key sources for this article include guidelines and documentation from NIOSH\/CDC (*Control of Smoke From Laser\/Electric Surgical Procedures*), OSHA (*Laser\/Electrosurgery Plume*), and AORN (*Guideline for Surgical Smoke Safety*), as well as official technical information from LiNA Medical regarding LiNA LapGuard™.<\/p>","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/images\/2026-06\/Air-Impurities-Removal-Systems-Inc-Surgical-Lasers-Operating-Room-Smoking-Guns.png?t=1787649653","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_images\/2026-06\/Air-Impurities-Removal-Systems-Inc-Surgical-Lasers-Operating-Room-Smoking-Guns.png?t=1788761842","tags":["Khói phẫu thuật","Hút khói phẫu thuật","Lọc khói phẫu thuật","Phẫu thuật nội soi","LiNA LapGuard"],"count_view":96,"seo_name":"surgical-smoke-in-laparoscopic-surgery-exposure-risks-and-the-role-of-at-source-smoke-control","date_update":1787648880,"date_created_format":1787649660,"meta_title":"Khói phẫu thuật: Nguy cơ và giải pháp hút lọc khói trong phòng mổ","meta_desc":"Khói phẫu thuật từ dao điện có thể chứa các hạt, khí và hợp chất hóa học gây phơi nhiễm trong phòng mổ. Tìm hiểu nguy cơ, kiểm soát khói và vai trò của bộ lọc khói nội soi LiNA LapGuard™.","meta_keyword":"khói phẫu thuật,hút khói phẫu thuật,lọc khói phẫu thuật,khói dao điện,hút khói dao điện,bộ lọc khói nội soi,LiNA LapGuard","qr_code":"https:\/\/psgmedical.com\/surgical-smoke-in-laparoscopic-surgery-exposure-risks-and-the-role-of-at-source-smoke-control","title_page":"News","relate_object_id":753594,"company_logo":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/images\/logo\/psgmedical_com-logo-new.png?t=1787641494","company_name":"https:\/\/psgmedical.com\/","company_email":"sale.psgmedical@gmail.com","company_phone":"0765.28.48.68","company_address":"8th Floor, Pearl Plaza, No 561 Dien Bien Phu, Thanh My Tay wards, Ho Chi Minh city, Viet Nam","company_fax":"","date_now":1789237805,"company_tags":["Assisted Reproductive Technology","IVF","Obstetrics","Gynecology","Radiotherapy Equipment","Soft Tissue Biopsy","Breast Lesion Localization Needles","Gold Markers","Specialized Operating Room Equipment","Medical Imaging Diagnostic Solutions"],"search_keyword":null,"facebook_comment":"https:\/\/psgmedical.com\/surgical-smoke-in-laparoscopic-surgery-exposure-risks-and-the-role-of-at-source-smoke-control","breadscrumb":[{"url":"https:\/\/psgmedical.com","name":"Home","icon":"","active":false},{"url":"https:\/\/psgmedical.com\/tin-tuc","name":"News","icon":"","active":false},{"url":"https:\/\/psgmedical.com\/internet-news","name":"Science News","icon":"","active":true}],"lang":{"lang":"en","locale":"en-US","code":"us"},"list_products_tmp":[],"list_section":[{"id":179039,"name":"SECTION-363","seo_name":"#w30s-section-179039","url":"#w30s-section-179039"},{"id":179040,"name":"SECTION-364","seo_name":"#w30s-section-179040","url":"#w30s-section-179040"},{"id":179041,"name":"SECTION-367","seo_name":"#w30s-section-179041","url":"#w30s-section-179041"},{"id":179060,"name":"SECTION-199","seo_name":"#w30s-section-179060","url":"#w30s-section-179060"},{"id":179061,"name":"SECTION-200","seo_name":"#w30s-section-179061","url":"#w30s-section-179061"},{"id":179042,"name":"SECTION-913","seo_name":"#w30s-section-179042","url":"#w30s-section-179042"},{"id":179043,"name":"SECTION-393","seo_name":"#w30s-section-179043","url":"#w30s-section-179043"},{"id":179044,"name":"SECTION-393","seo_name":"#w30s-section-179044","url":"#w30s-section-179044"}],"type_page":7,"id_page":91372,"widget_15129604":{"content_data":[{"id":28443,"title":"American","code":"us","is_expires":false,"is_active":0},{"id":28120,"title":"Tiếng Việt","code":"vn","is_expires":false,"is_active":1}]},"widget_15129614":{"content_data":{"content":""}},"widget_15129615":{"content_data":[]},"widget_15129617":{"content_data":{"content":"Tìm kiếm"}},"widget_15129608":{"content_data":{"content":"<div class=\"w30s-content cke_editable cke_editable_inline cke_contents_ltr cke_show_borders\" style=\"height: 100%; position: relative;\" tabindex=\"0\" spellcheck=\"false\" role=\"textbox\" aria-label=\"Rich Text Editor, editor3\" title=\"Rich Text Editor, editor3\" aria-describedby=\"cke_289\">Menu<\/p><\/div>"}},"widget_15129610":{"content_data":[]},"widget_15129612":{"content_data":{"content":"<\/span>"}},"widget_3947196":{"content_data":{"content":"Date:<\/p>"}},"widget_3947198":{"content_data":{"content":"|<\/p>"}},"widget_3947199":{"content_data":{"content":"View: <\/p>"}},"widget_3947207":{"content_data":{"content":"<div class=\"w30s-content cke_editable cke_editable_inline cke_contents_ltr cke_show_borders\" style=\"height: 100%; position: relative;\" tabindex=\"0\" spellcheck=\"false\" role=\"textbox\" aria-label=\"Rich Text Editor, editor1\" title=\"Rich Text Editor, editor1\" aria-describedby=\"cke_68\">Date:<\/p><\/div>"}},"widget_3947210":{"content_data":{"content":"<div class=\"w30s-content cke_editable cke_editable_inline cke_contents_ltr cke_show_borders\" style=\"height: 100%; position: relative;\" tabindex=\"0\" spellcheck=\"false\" role=\"textbox\" aria-label=\"Rich Text Editor, editor2\" title=\"Rich Text Editor, editor2\" aria-describedby=\"cke_203\">Views:<\/p><\/div>"}},"widget_3947201":{"content_data":{"content":"Related News<\/span>"}},"widget_3947203":{"content_data":[{"id":752115,"name":"Clinical Evidence - CORAZOR® UROMED Biopsy Device","desc":"The CORAZOR® UROMED biopsy device was used in a clinical study published in the *World Journal of Urology* (2025). In this study involving 636 patients undergoing transperineal prostate biopsies, the device was used to obtain tissue samples with an overall complication rate of just 1.9% and an infection rate of 1.1%, even without the use of prophylactic antibiotics.<\/p>","content":"<figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(4).png\"><\/figure><h3>Purpose<\/h3>Although the pursuit of effective and safe early detection methods for prostate cancer has led to advancements in non-invasive tools, there are approximately one million prostate biopsies per year performed annually in the EU [11]. The use of the transperineal approach to prostate biopsy is increasing because it offers a significantly reduced incidence of post-biopsy sepsis complications compared to transrectal biopsies and therefore is the recommended approach in the European Association of Urology guidelines. However, the consensus on the standard of care for antibiotic prophylaxis in some or all transperineal biopsy cases is only beginning to be established. As with transrectal biopsies, there are concerns about antibiotic stewardship, antibiotic side effects and labor and material costs associated with prophylaxis.<\/p><h3>Methods<\/h3>This retrospective study analyzed 636 patients who underwent transperineal prostate biopsies without the use of antibiotic prophylaxis between January 2019 and August 2020. The primary endpoint was the rate of postinterventional infectious complications, with secondary endpoints including the rate of general complications and associated risk factors.<\/p><h3>Results<\/h3>The rate of all complications was 1.9%. There were 7\/636 (1.1%) infectious complications, of which 3 (0.50%) were prostatitis, 1 (0.16%) was epididymitis, 2 (0.3%) were infections resulting in hospitalization and 1 (0.16%) urosepsis with ICU care. No identified risk factors were associated with infectious complications or post-interventional bleeding. Notably, the cohort was not systematically screened for bacteriuria before biopsy, and patients usually categorized as high risk for post-biopsy complications were not excluded. The rates of infectious complications and sepsis were lower than that reported for transrectal biopsies with antibiotic prophylaxis.<\/p><h3>Conclusion<\/h3>This study supports the relative safety of omitting antibiotic prophylaxis in transperineal prostate biopsies, showcasing a minimal infectious complication rate. The findings contribute to the ongoing discourse on antibiotic stewardship, emphasizing the need for judicious use to mitigate resistance, avoid allergic side effects and decrease the labor and material costs associated with transperineal prostate biopsy.<\/p>Keywords:<\/strong> Prostatic neoplasms [MeSH], Image-guided biopsy [MeSH], Transperineal, Transrectal, Fusion biopsy, Intraoperative complications [MeSH]<\/p><h2>Introduction<\/h2>The field of early prostate cancer detection has undergone substantial investigation to avoid unnecessary prostate biopsies, obtain accurate histopathological results and minimize morbidity. However, despite advances in non-invasive tools such as risk calculators, mpMRI, ultrasound and PSMA PET scan to determine the risk of prostate cancer, it is estimated that approximately one million prostate biopsies are performed annually in the European Union [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR11\">11<\/u><\/a>].<\/p>Because of fewer sepsis complications with use of the transperineal approach, EAU guidelines state that “The available evidence demonstrates that the transrectal approach should be abandoned in favour of the transperineal approach despite any possible logistical challenges”. It has been well established that antibiotic prophylaxis is necessary for the transrectal approach [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR6\">6<\/u><\/a>], likely due to fecal contamination of the biopsy needle as it passes through the rectal mucosa. However, the role of antibiotic prophylaxis in transperineal biopsies has been assessed over the last few years in many transperineal biopsy trials yet remains unclear [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR5\">5<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR9\">9<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR12\">12<\/u><\/a>–<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR15\">15<\/u><\/a>].<\/p>However, a metanalysis by Basourakos [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR1\">1<\/u><\/a>] showed a small, statistically significant lower risk of infectious complications with antibiotic prophylaxis while another metanalysis by Castellani [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR4\">4<\/u><\/a>] found no significant difference between groups using or omitting antibiotic prophylaxis in rates of infection, fever, sepsis or readmission.<\/p>The cavalier use of antibiotics coupled with growing rates of bacterial resistance have become a significant public health issue. A review of antibiotic prescribing in hospitals by Hulscher et al. stated that assessments have found that up to 50% of hospital antibiotic use is inappropriate in 20–50% of cases [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR7\">7<\/u><\/a>]. Correct use of antibiotics is crucial for allowing continued effective control of bacterial infection. If omitting antibiotic prophylaxis in a widely used procedure such as prostate biopsy is safe, its impact on public health could be of enormous importance [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR2\">2<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR3\">3<\/u><\/a>].<\/p>In our study, we retrospectively analyzed the safety of omitting antibiotic prophylaxis in transperineal prostate biopsy without periinterventional screening for bacteriuria. The primary endpoint is rate of postinterventional infectious complications. The secondary endpoint is general complication rate and associated risk factors.<\/p><h2>Materials and methods<\/h2><h3>Population<\/h3>We retrospectively analyzed 650 consecutive patients who received transperineal prostate biopsies in our urology clinic between January 2019 and August 2020.<\/p>Inclusion criteria were: suspicion of prostate cancer, pathological PSA value\/dynamics, pathological DRE, and\/or pathological MRI Cases with inadequate documentation were excluded. Of the 650 patients, 636 met this inclusion criteria (Fig.&nbsp;<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Fig1\">1<\/u><\/a>).<\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(8).png\"><\/figure><h3>Biopsy procedure<\/h3>Transperineal prostate biopsies were performed as outpatient procedures. Before completing the procedure, a short history was obtained, particularly asking about any prior operations of the genitourinary tract or history of indwelling catheters, family history, and existing diseases. A biopsy was not performed if the patient was taking anticoagulant medication, except for aspirin. Platelet aggregation inhibitors such as clopidogrel, ticagrelor etc. had to be paused for 7 days prior to the biopsy procedure. After excluding contraindications for prostate biopsy, general consent was obtained. No blood or urine samples were taken before the intervention.<\/p>The procedure was performed in lithotomy. The scrotum and penis were taped to the suprapubic area (unsterile Leukoplast– Hypafix 15&nbsp;cm x 20&nbsp;m, Beiersdorf AG, Hamburg, Germany). The perineum was shaved when necessary, and gross dirt particles were removed. Antiseptic disinfection was completed with 7.5% Povidone-Iodine solution (Braunol 7.5% Povidon Iod, Braun, Germany). Two dedicated urologists performed the transperineal biopsies. Local anesthesia of the skin and periprostatic.<\/p>blockade were performed with a 20<\/i> gauge needle (Sterican 20 G 0.9 × 70&nbsp;mm, Braun, Germany) and 20&nbsp;ml of Mepivicain 10&nbsp;mg\/ml (Mecain, Eugia Pharma PUREN, Malta). Periprostatic block was achieved by finger guidance with the injection of mepivicain below the prostatic apex, bilaterally in the levator ani, and along the needle’s path. 5 to 10&nbsp;min were given for the optimal effect of local anesthesia. Biopsies were performed with a disposable template grid (Template Grid 17\/18GA, Civco, Iowa, United States of America). A 24&nbsp;cm long 18-gauge needle with a hand fire system (CORAZOR, UROMED, Germany) was used for sample collection.<\/p>Systematic biopsies were performed under local anesthesia (periprostatic nerve block). In MRI Fusion biopsy procedures, we added sedation to the local anesthesia (midazolam and ketamine) to minimize the risk of movement during the procedure.<\/p>UroNav Philips Invivo (Amsterdam, Netherlands) with a template grid was utilized for fusion biopsy combined with the BK 3000, BK Medical (Nærum, Denmark) rectal ultrasound. Systematic biopsies were performed with five cores per half gland. MRI fusion biopsies complemented systematic biopsies with 3 to 4 biopsies per lesion, depending on lesion size and counts.<\/p>After checking for gross hematuria and the ability to void, the patient was dismissed.<\/p><h3>Outcome variables<\/h3>We classified the cases according to the following categorical outcome variables: previous biopsy, under active surveillance, previous prostatitis, diabetes mellitus, diabetes mellitus medication, obesity (cut-off for body mass index &gt; 35), immunosuppression, anticoagulant therapy (aspirin, clopidogrel, phenprocoumon, or a direct oral anticoagulant), indwelling catheter, previous surgery, DRE, performing urologist, type of anesthesia, ISUP grade group, type of complication. In addition, we chose the following continuous outcome variables: age (years), prostate volume (cc), number of MRI lesions, number of cores, and the number of positive cores.<\/p><h3>Statistical methods<\/h3>Statistical analyses were conducted using R (Version 4.0.5 for Windows). Non-parametric statistics were applied. Data were presented as raw values and percentages and medians with lower (Q1) and upper quartiles (Q3). We checked for relations between categorical data (prostate biopsy technique, prostate cancer detection) using chi-square test of independence. Correlation between PIRADS lesions and histological results (ISUP) of the biopsy was checked with the Spearman´s correlation test. We checked for risk factors using Generalized Linear Model (GLM). The threshold for a statistically significant difference was p<\/i> &lt; 0.05.<\/p><h3>Data source<\/h3>We retrospectively obtained data from medical charts (i.e., categorical, and continuous outcome variables) between January 2022 and December 2022.<\/p><h3>Bias<\/h3>We encountered two types of bias:<\/p>Selection bias– the retrospective nature of the trial.<\/p>Follow-up bias: follow-up data were collected by chart review from charts of our clinic. Outpatient complication treatment (i.e., prescription of antibiotics in the postinterventional course) by another physician may have occurred without being noted in our chart reviews.<\/p><h2>Results<\/h2>Overall, 636 patients (median age 68 (62,73) years) with prostate cancer suspicion were included in this study. Demographics and biopsy results are highlighted in Tables&nbsp;<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab1\">1<\/u><\/a> and <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab2\">2<\/u><\/a>, and <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab3\">3<\/u><\/a>. Of the 255 systematic biopsies performed, 125 cases of prostate cancer were confirmed histologically. In comparison, 238 cases of prostate cancer were confirmed histologically out of 378 fusion biopsies. Prostate cancer was significantly more frequently detected using fusion biopsies (p<\/i> &lt; 0.001). High-grade prostate cancer (ISUP &gt; 3) was detected in 29.4% of systematic biopsies and 15.1% of fusion biopsies. This difference was statistically significant (p<\/i> &lt; 0.0001).<\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(10).png\"><\/figure><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(11).png\"><\/figure><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(14).png\"><\/figure><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(15).png\"><\/figure>A Spearman’s rank correlation was conducted to assess the relationship between PIRADS score and ISUP grade in the fusion biopsies. The analysis revealed a statistically significant positive correlation (ρ = 0.467, <\/span>p<\/i> &lt; 0.001), suggesting that higher PIRADS scores are associated with higher ISUP grades (Table&nbsp;<\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab4\">4<\/u><\/a>).<\/span><\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(18).png\"><\/figure>In total, we recorded 12 complications, for a complication rate of 1.9%. Details of Clavien Dindo grade are described in Table&nbsp;<\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab5\">5<\/u><\/a>. We found 1.1% (7\/636) infectious complications needing antibiotic treatment (see Table&nbsp;<\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab6\">6<\/u><\/a>). Three patients diagnosed with urosepsis were evaluated based on systemic inflammatory response syndrome (SIRS) parameters (see Table&nbsp;<\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab7\">7<\/u><\/a>). All patients presented with elevated body temperature (≥ 39.8&nbsp;°C) and leukocytosis (&gt; 12 × 10⁹\/L). Heart rates varied, with two patients exceeding 90&nbsp;bpm, while one remained below this threshold. Respiratory rate data were unavailable. Blood cultures confirmed <\/span>Escherichia coli<\/i> (<\/span>E. coli<\/i>) as the causative pathogen in all cases. Two patients were treated with intravenous antibiotics on a normal ward and showed clinical improvement. However, one patient, presenting with the highest leukocyte count (30.9 × 10⁹\/L) and a heart rate of 96&nbsp;bpm, required intensive care unit (ICU) admission due to the severity of their condition.<\/span><\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(20).png\"><\/figure><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(21).png\"><\/figure><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(24).png\"><\/figure>Four patients reported gross hematuria requiring bladder irrigation. One patient needed catheterization due to urinary retention. For the 11 patients who were excluded from data analysis, no complications could have been identified in chart review.<\/p>A patient is diagnosed with SIRS if they meet at least two of the following criteria:<\/p>Temperature<\/strong>: A temperature above 100.4&nbsp;°F (38&nbsp;°C) or below 96.8&nbsp;°F (36&nbsp;°C).<\/p>Heart rate<\/strong>: A heart rate above 90 beats per minute.<\/p>Respiratory rate<\/strong>: A respiratory rate above 20 breaths per minute, or a partial pressure of carbon dioxide below 32&nbsp;mm Hg.<\/p>White blood cell count<\/strong>: A white blood cell count above 12 × 10⁹\/L or below 4 × 10⁹\/L; or more than 10% immature forms.<\/p>We could not determine any risk factors for infectious complications (age p<\/i> = 0.44, diabetes mellitus p<\/i> = 0.23, indwelling catheter p<\/i> = 0.26, number of cores p<\/i> = 0.6, prostate volume p<\/i> = 0.44), post-interventional bleeding (age p<\/i> = 0.75, under anticoagulant agent p<\/i> = 0.5, number of cores p<\/i> = 0.14, prostate volume p<\/i> = 0.10), PSA level &lt; 20 vs. &gt; 20 ng\/ml p<\/i> = 0.12). Table&nbsp;<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab7\">7<\/u><\/a> highlights those patients who suffered from an infectious complication and their clinical details (see Table&nbsp;<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab8\">8<\/u><\/a>).<\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-08\/image(26).png\"><\/figure><h2>Discussion<\/h2><h3>Main findings<\/h3>Our study reported on complications after transperineal prostate biopsy without peri-interventional antibiotic prophylaxis and without routine screening for bacteriuria in a single-center retrospective cohort of 636 patients.<\/p>Most trials do not mention if patients were excluded from the trial after performing urine analysis showing bacteriuria. In our cohort, patients were not systematically screened for underlying UTI\/bacteriuria if they did not report signs or symptoms for a UTI. As the transperineal route does not systematically injure the rectal mucosa, there is little rationale for systematic screening of the rectal flora.<\/p>Furthermore, we did not exclude patients with a “high risk for infectious complication after prostate biopsy.” High risk for infectious complication after prostate biopsy is not clearly defined. In the NORAPP trial [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR8\">8<\/u><\/a>], the following criteria were defined for high risk: indwelling urinary catheter, immunodeficiencies, high risk of infective endocarditis, or a history of thromboembolic disease.<\/p>As mentioned above, in our daily clinical practice we only check for an underlying UTI with urine analysis before performing a prostate biopsy if obvious signs or symptoms for a significant UTI as fewer, painful voiding abnormalities or visible pyuria with an indwelling catheter are apparent. If so, the scheduled biopsy is postponed, with further diagnostics, including urine microscopy and cultures, guiding treatment. In our cohort of 636 consecutive patients, there were no obvious signs or symptoms for a significant UTI and consequently no urine analysis was performed. As a result, there was no need to postpone any prostate biopsy due to an asymptomatic UTI. While postponing the biopsy remains an option in cases of confirmed infection, we did not encounter such a situation in our study.<\/p>We reported a complication rate of 1.9% with 11 Clavien Dindo grade (CD) 2 complications and one CD 4 complication. The most common complications were infectious complications. The rate of infectious complications for the transperineal prostate biopsy without antibiotic prophylaxis in our cohort (about 1%) is much lower than what has generally been reported for transrectal prostate biopsy with antibiotic prophylaxis (approx. 5–7%) [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#CR10\">10<\/u><\/a>]. Notably, three of the infectious complications in our cohort were cases of sepsis, as defined by the SIRS criteria. The post-biopsy sepsis rate is a key factor driving the shift among urologists toward the transperineal approach. It must be emphasized that post-biopsy infectious complications are not necessarily a surrogate for post-biopsy sepsis.<\/p><h3>Findings of biopsy results<\/h3>Histologically confirmed prostate cancer was more often found in fusion biopsy than in systematic biopsies (Tables&nbsp;<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab2\">2<\/u><\/a> and <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12179225\/#Tab3\">3<\/u><\/a>). High-grade prostate cancer (ISUP &gt; 3) was more frequently found in the group who underwent systematic biopsies. An explanation could be that we did not perform upfront MRIs when there was a high risk for prostate cancer, such as PSA &gt; 20 ng\/ml or suspicious DRE. Therefore, systematic biopsies had a negative selection bias for ISUP grade compared to the group of MRI fusion biopsies.<\/p><h3>Limitations<\/h3>The main limitation of this study is that follow-up data has been collected with a retrospective chart review. The total number of low-grade complications may have been a little higher, as not all patients may have been referred back to our clinic nor do they all remember if they had been prescribed an oral medication (i.e. antibiotics) by a private consultant. Higher-grade complications (Clavien Dindo Grade &gt; 2) were likely not missed, as our tertiary medical care center comprises the only urological unit in a radius of about 75&nbsp;km. Risk factors for infectious or bleeding complications did not meet statistical significance. Indeed 2 out of the 3 patients with an occurring urosepsis after the procedure had a pre biopsy PSA level over 20ng\/ml (28.3 and 63.0ng\/ml). This might lead to the estimation to screen those patients with very high PSA levels routinely on UTIs with pre-interventional urine cultures to avoid complications although this paraemter reached no significance in our study. This may have been due to our cohort’s relatively low number of complications. Our cohort with 650 patients and less than 2% complications may be insufficient to provide a correct insight into the prevalence of complications. A larger cohort may be necessary when analyzing complications and their risk factors with low incidence.<\/p><h2>Conclusions<\/h2>Our report confirmed existing data showing a low number of infectious complications when using the transperineal route for prostate biopsies despite the omission of antibiotic prophylaxis and despite the omission of systematic screening for underlying bacteriuria. Omitting antibiotic prophylaxis and omitting screening for bacteriuria seems to be safe in transperineal prostate biopsies.<\/p><h2>Acknowledgements<\/h2>None.<\/p><h2>Author contributions<\/h2>Conceptualization, methods, and investigation, F.L., T.S.; Performing prostate biopsies and documentation, JV, OL; Data mining, investigation and draft preparation was incorporated in academic formulation for a medical doctor thesis at the University Medical Center of the Johannes Gutenberg-University Mainz; formal analysis, F.L.; writing—original draft preparation, F.L.; writing—review and editing, F.L., T.S., A.N.; visualization, F.L.; conceptualization and supervision, A.N. All authors have read and agreed to the published version of the manuscript.<\/p><h2>Funding<\/h2>Open Access funding enabled and organized by Projekt DEAL. This research received no funding.<\/p><h2>Data availability<\/h2>No datasets were generated or analysed during the current study.<\/p><h2>Declarations<\/h2><h3>Institutional review board<\/h3>This retrospective cohort study was conducted in accordance with the Declaration of Helsinki and approved by our local ethics committee (Ethics Committee of the Mainz Medical Association (2022–16318)). Further, this study is reported in accordance with the STROBE statement guideline for cohort studies.<\/p><h3>Consent for publication<\/h3>The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of World Journal of Urology and\/or the editor(s). World Journal of Urology and\/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.<\/p><h3>Informed consent<\/h3>Patient consent was waived due to the retrospective nature of this study. Further, given the provided information, patients cannot be identified (including by the patients themselves).<\/p><h3>Competing interests<\/h3>The authors declare no competing interests.<\/p><h2>Footnotes<\/h2>Publisher’s note<\/strong><\/p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.<\/p><h2>References<\/h2><ul><li>1.Basourakos SP, Alshak MN, Lewicki PJ, Cheng E, Tzeng M, DeRosa AP, Allaway MJ, Ross AE, Schaeffer EM, Patel HD, Hu JC, Gorin MA (2022) Role of prophylactic antibiotics in transperineal prostate biopsy: A systematic review and Meta-analysis. Eur Urol Open Sci 37:53–63. 10.1016\/j.euros.2022.01.001 [<a href=\"https:\/\/doi.org\/10.1016\/j.euros.2022.01.001\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8883190\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35243391\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Basourakos%20SP,%20Alshak%20MN,%20Lewicki%20PJ,%20Cheng%20E,%20Tzeng%20M,%20DeRosa%20AP,%20Allaway%20MJ,%20Ross%20AE,%20Schaeffer%20EM,%20Patel%20HD,%20Hu%20JC,%20Gorin%20MA%20(2022)%20Role%20of%20prophylactic%20antibiotics%20in%20transperineal%20prostate%20biopsy:%20A%20systematic%20review%20and%20Meta-analysis.%20Eur%20Urol%20Open%20Sci%2037:53%E2%80%9363.%2010.1016\/j.euros.2022.01.001\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>2.Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M (2014) A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 14:1–25. 10.1186\/1471-2334-14-13 [<a href=\"https:\/\/doi.org\/10.1186\/1471-2334-14-13\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3897982\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24405683\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Bell%20BG,%20Schellevis%20F,%20Stobberingh%20E,%20Goossens%20H,%20Pringle%20M%20(2014)%20A%20systematic%20review%20and%20meta-analysis%20of%20the%20effects%20of%20antibiotic%20consumption%20on%20antibiotic%20resistance.%20BMC%20Infect%20Dis%2014:1%E2%80%9325.%2010.1186\/1471-2334-14-13\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>3.Bootsma AMJ, Laguna Pes MP, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: A systematic review. Eur Urol 54:1270–1286. 10.1016\/j.eururo.2008.03.033 [<a href=\"https:\/\/doi.org\/10.1016\/j.eururo.2008.03.033\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18423974\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Bootsma%20AMJ,%20Laguna%20Pes%20MP,%20Geerlings%20SE,%20Goossens%20A%20(2008)%20Antibiotic%20prophylaxis%20in%20urologic%20procedures:%20A%20systematic%20review.%20Eur%20Urol%2054:1270%E2%80%931286.%2010.1016\/j.eururo.2008.03.033\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>4.Castellani D, Pirola GM, Law YXT, Gubbiotti M, Giulioni C, Scarcella S, Wroclawski ML, Chan E, Chiu PKF, Teoh JYC, Gauhar V, Rubilotta E (2022) Infection rate after transperineal prostate biopsy with and without prophylactic antibiotics: results from a systematic review and Meta-Analysis of comparative studies. J Urol 207:25–34 [<a href=\"https:\/\/doi.org\/10.1097\/JU.0000000000002251\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34555932\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Castellani%20D,%20Pirola%20GM,%20Law%20YXT,%20Gubbiotti%20M,%20Giulioni%20C,%20Scarcella%20S,%20Wroclawski%20ML,%20Chan%20E,%20Chiu%20PKF,%20Teoh%20JYC,%20Gauhar%20V,%20Rubilotta%20E%20(2022)%20Infection%20rate%20after%20transperineal%20prostate%20biopsy%20with%20and%20without%20prophylactic%20antibiotics:%20results%20from%20a%20systematic%20review%20and%20Meta-Analysis%20of%20comparative%20studies.%20J%20Urol%20207:25%E2%80%9334\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>5.Ding Xfei, Luan Y, Lu S, ming, Zhou G, chen, Huang T, bao, Zhu L yong, Guo C (2021) hao Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy. World J Urol 39:2463–2467. 10.1007\/s00345-020-03454-y [<a href=\"https:\/\/doi.org\/10.1007\/s00345-020-03454-y\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32949254\/\">PubMed<\/u><\/a>]<\/li><li>6.El Z, Oac C, Netto R (2011) Antibiotic prophylaxis for transrectal prostate biopsy (Review) [<a href=\"https:\/\/doi.org\/10.1002\/14651858.CD006576.pub2\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12301957\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21563156\/\">PubMed<\/u><\/a>]<\/li><li>7.Hulscher ME, van der Grol RP (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10:167–175. 10.1016\/S1473-3099(10)70027-X [<a href=\"https:\/\/doi.org\/10.1016\/S1473-3099(10)70027-X\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20185095\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Hulscher%20ME,%20van%20der%20Grol%20RP%20(2010)%20Antibiotic%20prescribing%20in%20hospitals:%20a%20social%20and%20behavioural%20scientific%20approach.%20Lancet%20Infect%20Dis%2010:167%E2%80%93175.%2010.1016\/S1473-3099(10)70027-X\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>8.Jacewicz M, Günzel K, Rud E, Sandbæk G, Magheli A, Busch J, Hinz S, Baco E (2022) Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial. Lancet Infect Dis 22:1465–1471. 10.1016\/S1473-3099(22)00373-5 [<a href=\"https:\/\/doi.org\/10.1016\/S1473-3099(22)00373-5\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35839791\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Jacewicz%20M,%20G%C3%BCnzel%20K,%20Rud%20E,%20Sandb%C3%A6k%20G,%20Magheli%20A,%20Busch%20J,%20Hinz%20S,%20Baco%20E%20(2022)%20Antibiotic%20prophylaxis%20versus%20no%20antibiotic%20prophylaxis%20in%20transperineal%20prostate%20biopsies%20(NORAPP):%20a%20randomised,%20open-label,%20non-inferiority%20trial.%20Lancet%20Infect%20Dis%2022:1465%E2%80%931471.%2010.1016\/S1473-3099(22)00373-5\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>9.Kohl T, Sigle A, Kuru T, Salem J, Rolfs H, Kowalke T, Suarez-Ibarrola R, Michaelis J, Binder N, Jilg CA, Miernik A, Grabbert MT, Schultze-Seemann W, Gratzke C, Porres D (2021) Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up. Prostate Cancer Prostatic Dis 1–5. 10.1038\/s41391-021-00423-3 [<a href=\"https:\/\/doi.org\/10.1038\/s41391-021-00423-3\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9184280\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34267332\/\">PubMed<\/u><\/a>]<\/li><li>10.Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198:329–334. 10.1016\/j.juro.2017.01.103 [<a href=\"https:\/\/doi.org\/10.1016\/j.juro.2017.01.103\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28363690\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Liss%20MA,%20Ehdaie%20B,%20Loeb%20S,%20Meng%20MV,%20Raman%20JD,%20Spears%20V,%20Stroup%20SP%20(2017)%20An%20update%20of%20the%20American%20urological%20association%20white%20paper%20on%20the%20prevention%20and%20treatment%20of%20the%20more%20common%20complications%20related%20to%20prostate%20biopsy.%20J%20Urol%20198:329%E2%80%93334.%2010.1016\/j.juro.2017.01.103\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>11.van den Mottet N, Van den Briers E, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Grummet J, van der Henry AM, Lam TB, Lardas M, Liew M, Mason MD, Moris L, van der Oprea-Lager DE, Rouvière O, Schoots IG, Tilki D, Wiegel T, Willemse PPM, Cornford P (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79:243–262. 10.1016\/j.eururo.2020.09.042 [<a href=\"https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33172724\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?van%20den%20Mottet%20N,%20Van%20den%20Briers%20E,%20Cumberbatch%20MG,%20De%20Santis%20M,%20Fanti%20S,%20Fossati%20N,%20Gandaglia%20G,%20Gillessen%20S,%20Grivas%20N,%20Grummet%20J,%20van%20der%20Henry%20AM,%20Lam%20TB,%20Lardas%20M,%20Liew%20M,%20Mason%20MD,%20Moris%20L,%20van%20der%20Oprea-Lager%20DE,%20Rouvi%C3%A8re%20O,%20Schoots%20IG,%20Tilki%20D,%20Wiegel%20T,%20Willemse%20PPM,%20Cornford%20P%20(2021)%20EAU-EANM-ESTRO-ESUR-SIOG%20guidelines%20on%20prostate%20Cancer%E2%80%942020%20update.%20Part%201:%20screening,%20diagnosis,%20and%20local%20treatment%20with%20curative%20intent.%20Eur%20Urol%2079:243%E2%80%93262.%2010.1016\/j.eururo.2020.09.042\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>12.Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, Hanegbi U, Landau A, Snow R, Grummet J (2017) Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol 35:1199–1203. 10.1007\/s00345-016-1985-1 [<a href=\"https:\/\/doi.org\/10.1007\/s00345-016-1985-1\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27987032\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Pepdjonovic%20L,%20Tan%20GH,%20Huang%20S,%20Mann%20S,%20Frydenberg%20M,%20Moon%20D,%20Hanegbi%20U,%20Landau%20A,%20Snow%20R,%20Grummet%20J%20(2017)%20Zero%20hospital%20admissions%20for%20infection%20after%20577%20transperineal%20prostate%20biopsies%20using%20single-dose%20cephazolin%20prophylaxis.%20World%20J%20Urol%2035:1199%E2%80%931203.%2010.1007\/s00345-016-1985-1\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>13.Sigle A, Suarez-Ibarrola R, Pudimat M, Michaelis J, Jilg CA, Miernik A, Grabbert MT, Schultze-Seemann W, Gratzke C, Schlager D (2021) Safety and side effects of transperineal prostate biopsy without antibiotic prophylaxis. Urologic Oncology: Seminars Original Investigations 39:782e1. 10.1016\/j.urolonc.2021.02.016 [<a href=\"https:\/\/doi.org\/10.1016\/j.urolonc.2021.02.016\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33736977\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Sigle%20A,%20Suarez-Ibarrola%20R,%20Pudimat%20M,%20Michaelis%20J,%20Jilg%20CA,%20Miernik%20A,%20Grabbert%20MT,%20Schultze-Seemann%20W,%20Gratzke%20C,%20Schlager%20D%20(2021)%20Safety%20and%20side%20effects%20of%20transperineal%20prostate%20biopsy%20without%20antibiotic%20prophylaxis.%20Urologic%20Oncology:%20Seminars%20Original%20Investigations%2039:782e1.%2010.1016\/j.urolonc.2021.02.016\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>14.Sigle A, Suarez-Ibarrola R, Pudimat M, Michaelis J, Jilg CA, Miernik A, Grabbert MT, Schultze-Seemann W, Gratzke C, Schlager D, Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, Hanegbi U, Landau A, Snow R, Grummet J, Baba K, Sekine Y, Miyazawa Y, Syuto T, Nomura M, Koike H, Matsui H, Shibata Y, Ito K, Suzuki K (2017) Safety and side effects of transperineal prostate biopsy without antibiotic prophylaxis. World J Urol 39:1199–1203. 10.1007\/s00345-016-1985-1 [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Sigle%20A,%20Suarez-Ibarrola%20R,%20Pudimat%20M,%20Michaelis%20J,%20Jilg%20CA,%20Miernik%20A,%20Grabbert%20MT,%20Schultze-Seemann%20W,%20Gratzke%20C,%20Schlager%20D,%20Pepdjonovic%20L,%20Tan%20GH,%20Huang%20S,%20Mann%20S,%20Frydenberg%20M,%20Moon%20D,%20Hanegbi%20U,%20Landau%20A,%20Snow%20R,%20Grummet%20J,%20Baba%20K,%20Sekine%20Y,%20Miyazawa%20Y,%20Syuto%20T,%20Nomura%20M,%20Koike%20H,%20Matsui%20H,%20Shibata%20Y,%20Ito%20K,%20Suzuki%20K%20(2017)%20Safety%20and%20side%20effects%20of%20transperineal%20prostate%20biopsy%20without%20antibiotic%20prophylaxis.%20World%20J%20Urol%2039:1199%E2%80%931203.%2010.1007\/s00345-016-1985-1\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>15.Xiang J, Yan H, Li J, Wang X, Chen H, Zheng X (2019) Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: A systematic review and meta-analysis. World J Surg Oncol 17:1–11. 10.1186\/s12957-019-1573-0 [<a href=\"https:\/\/doi.org\/10.1186\/s12957-019-1573-0\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6375152\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30760274\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?Xiang%20J,%20Yan%20H,%20Li%20J,%20Wang%20X,%20Chen%20H,%20Zheng%20X%20(2019)%20Transperineal%20versus%20transrectal%20prostate%20biopsy%20in%20the%20diagnosis%20of%20prostate%20cancer:%20A%20systematic%20review%20and%20meta-analysis.%20World%20J%20Surg%20Oncol%2017:1%E2%80%9311.%2010.1186\/s12957-019-1573-0\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><\/ul><h2>Associated Data<\/h2>This section collects any data citations, data availability statements, or supplementary materials included in this article.<\/i><\/p><h3>Data Availability Statement<\/h3>No datasets were generated or analysed during the current study.<\/p>","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/images\/2026-08\/Carozar-device-03.jpeg?t=1785925834","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_images\/2026-08\/Carozar-device-03.jpeg?t=1788692685","tags":"","count_view":145,"seo_name":"clinical-evidence-corazor-uromed-biopsy-device","date_update":1785927840,"date_created_format":1785929382,"meta_title":"CORAZOR® UROMED Biopsy Device được sử dụng trong nghiên cứu lâm sàng","meta_desc":"CORAZOR® UROMED Biopsy Device được sử dụng trong nghiên cứu lâm sàng trên 636 bệnh nhân đăng trên World Journal of Urology (2025), ghi nhận tỷ lệ biến chứng chỉ 1,9% và tỷ lệ nhiễm trùng 1,1% trong sinh thiết tuyến tiền liệt qua tầng sinh môn.","meta_keyword":"CORAZOR UROMED,CORAZOR Biopsy Device,UROMED Biopsy Device,nghiên cứu lâm sàng CORAZOR,Clinical Evidence CORAZOR,World Journal of Urology 2025,sinh thiết tuyến tiền liệt,transperineal prostate biopsy,sinh thiết qua tầng sinh môn,biopsy device Germany,biops","qr_code":"https:\/\/psgmedical.com\/clinical-evidence-corazor-uromed-biopsy-device"},{"id":747183,"name":"Why is egg retrieval considered the \"key\" to the success of the IVF process?","desc":"In the field of assisted reproductive technology, the success of an IVF cycle depends not only on the ovulation induction protocol or embryo culture technique, but also on the smallest technical details at the time of oocyte retrieval (OPU). The oocyte retrieval needle is not just a tool; it is the doctor's \"extended arm\" in accessing and retrieving the oocytes in the safest way possible.<\/p>","content":"1. Why is the Oocyte Aspiration Needle the Most Important Segment?<\/strong><\/p>The oocyte aspiration procedure is the first invasive procedure and also the foundation for obtaining high-quality oocyte cells. An unsuitable needle can lead to consequences:<\/p>Tissue damage: Causes pain and increases the risk of bleeding for the patient.<\/p>Oocyte loss: Poor sharpness or suboptimal needle lumen results in a low oocyte retrieval rate.<\/p>Impact on oocyte quality: Excessive friction or unstable suction can negatively impact oocyte development immediately after retrieval.<\/p>Therefore, this is the segment that every IVF center prioritizes in its equipment investment portfolio.<\/p>&nbsp;<\/p>2. The Technological Race in the Market Today<\/strong> Currently, the oocyte aspiration needle market is witnessing fierce competition among major players. Manufacturers are no longer competing solely on price but are focusing on \"echogenicity\" and \"tissue-protecting technology.\" Clinicians are becoming increasingly demanding: they need needles that display sharply on the ultrasound screen, are soft enough not to damage the ovaries, yet strong enough to handle cases with difficult uterine conditions.<\/p>&nbsp;<\/p>3. Mona Lisa Needle: A Bright Spot in the High-End Segment<\/strong> In this context, the Mona Lisa needle emerges as an optimal solution, designed to thoroughly address the pain points of IVF doctors.<\/p>Why is the Mona Lisa needle the superior choice?<\/p>Superior ultrasound visibility: The Mona Lisa's strongest point is its ability to display clearly along the entire length of the needle. This allows doctors to accurately locate the ovarian follicle without spending too much time searching, significantly reducing procedure time.<\/p>\"Smart\" needle design: Superior sharp needle technology minimizes penetration force, reducing ovarian tissue tearing. This results in reduced bleeding and a more comfortable experience for patients after waking up.<\/p>High-quality materials: Mona Lisa needles meet the strictest biosafety standards, minimizing changes to the intracellular environment of the ovum during its journey through the needle.<\/p>&nbsp;<\/p>4. Mona Lisa's contribution to customer decisions<\/strong> When an IVF center chooses Mona Lisa, they are not just buying a needle; they are buying peace of mind and a higher success rate:<\/p>For doctors: Confidence in procedure execution, shorter procedure times, and complete patient satisfaction.<\/p>For the center: Enhanced reputation for service quality, reduced risk of complications for patients – a key factor in attracting new clients to the IVF center.<\/p>Conclusion:<\/strong> The choice of Mona Lisa is a testament to the serious and systematic investment of assisted reproductive centers. With its perfect combination of display technology and patient safety, Mona Lisa deserves to be the \"gold standard\" choice in the IVF equipment basket of any professional center.<\/p>","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/Kim-choc-hut-trung-Mona-Lisa.png?t=1780685539","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/Kim-choc-hut-trung-Mona-Lisa.png?t=1788692725","tags":["Thiết bị IVF","Kim chọc hút noãn","Dụng cụ hỗ trợ sinh sản","Mona Lisa IVF","Kim chọc hút 17G"],"count_view":280,"seo_name":"why-is-egg-retrieval-considered-the-key-to-the-success-of-the-ivf-process","date_update":1780886160,"date_created_format":1780886812,"meta_title":"Is Egg retrieval the key to success in IVF?","meta_desc":"Learn why the open-heart surgery (OPU) procedure is considered a key factor in determining the success rate of in-vitro fertilization (IVF) and the importance of specialized equipment.","meta_keyword":"Egg retrieval,OPU,oocyte retrieval procedure,IVF procedure,IVF success,egg retrieval equipment","qr_code":"https:\/\/psgmedical.com\/why-is-egg-retrieval-considered-the-key-to-the-success-of-the-ivf-process"},{"id":747174,"name":"CLINICAL REPORT ON COIL MARKER USING ULTRASOUND GUIDANCE OF VACUUM-ASSISTED BREAST BIOPSY","desc":"Subsequent Marking under Ultrasound Guidance of Vacuum-Assisted Breast Biopsy Areas after Receipt of Histology: A Feasibility Study of a New Technique<\/p>","content":"<h2>Abstract<\/h2><h3>Purpose<\/h3>The aim of this study was to evaluate the feasibility and the accuracy of a secondary, metachronous ultrasound (US)-guided marking of the stereotactic vacuum-assisted breast biopsy (ST-VABB) area.<\/p><h3>Materials and Methods<\/h3>The institutional ethics committee approved the study. The retrospective study included 98 patients. In ST-VABB of 45 women, no tissue markers were deployed at the biopsy site, even if no residual calcifications remained. After histology proved the necessity for a subsequent operation, the biopsy site was marked under US guidance using a coil marker. All interventions were technically successful. No complications occurred. Mammography was done to visualize the coil deployment. The distances from the center of the lesion and the biopsy cavity to the coil location were measured in both planes to evaluate the accuracy of the marking procedure.<\/p><h3>Results<\/h3>In 24 of the 46 cases, the whole lesion was biopsied without residual elements. The mean time between ST-VABB and sonographic marking of the lesion was 9.7 days (median 6.5). The biopsy cavity could be detected in 40 (87%) cases and thus marked exactly. The mean time of US-guided marking was 12.5 min. The mean distance between the coil and the target lesion was 0.6 ± 1.5 cm in the craniocaudal (cc) view and 0.5 ± 1.5 cm in the mediolateral (ml) view for all markings. The mean delta value from the distance nipple–original lesion and from the distance nipple–coil was 0.85 ± 1.2 cm (median 0.5) in the cc view and 0.88 ± 1.2 cm (median 0.6) in the ml view for all cases. Clip migration was not observed.<\/p><h3>Conclusion<\/h3>Our study demonstrates the feasibility and the technical success of secondary metachronous coil marking of the biopsy site under US guidance after receipt of histology. This approach seems to be a cost-effective alternative to the standard procedure of the primary coil marking especially in all completely removed lesions. It may offer advantages for allergic patients.<\/p>Keywords:<\/strong> Breast cancer, Diagnostic markers, Stereotactic vacuum biopsy, Ultrasound<\/p><h2>Introduction<\/h2>Coil or clip marking of a breast lesion after percutaneous biopsy has been reported for over 20 years [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B1\">1<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B2\">2<\/u><\/a>]. Breast tissue markers are supposed to facilitate correlation across imaging methods, preoperative planning, and oncological surveillance [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B3\">3<\/u><\/a>]. After percutaneous stereotactic vacuum-assisted breast biopsy (ST-VABB), a clip or coil is usually inserted into the biopsy site to guarantee identification of the area if the patient requires a subsequent operation. Marking is especially necessary if the lesion is completely removed by needle biopsy and the histology warrants further excision [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B4\">4<\/u><\/a>]. There are a variety of commercially available clips and coils [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B5\">5<\/u><\/a>]. The position of breast tissue markers may differ substantially from the location of the biopsy site [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B6\">6<\/u><\/a>]. Studies of the precision of clip placement show that 2–28% of clips [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B7\">7<\/u><\/a>] are more than 1 cm from the target [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B1\">1<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B2\">2<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B8\">8<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B9\">9<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B10\">10<\/u><\/a>]. Migration of the clip following ST-VABB is an accepted risk of the procedure [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B8\">8<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B11\">11<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B12\">12<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B13\">13<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B14\">14<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B15\">15<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B16\">16<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B17\">17<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B18\">18<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B19\">19<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B20\">20<\/u><\/a>]. The accurate placement of a tissue marker is of utmost importance for patients requiring neoadjuvant chemotherapy and undergoing complete tumor remission [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B21\">21<\/u><\/a>]. Another aspect is the additional cost of tissue markers [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B3\">3<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B12\">12<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B22\">22<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B23\">23<\/u><\/a>]. It is assumed that about two-thirds of all cases with coil marking could be avoided (in case of a negative biopsy) [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B24\">24<\/u><\/a>]. Also, the fact of getting a foreign body implanted with potential localization error, migration, and re-intervention or allergic reaction is of importance. If no surgery is needed, it is supposed to remain in the breast for a whole lifetime. In the concept of metachronous marker placement, the implantation of a foreign body is only performed if an operative excision is planned after receipt of histology [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B3\">3<\/u><\/a>]. In this case, it becomes a temporary and urgently needed step of intervention. As an advantage, clip migration could be avoided and reduced by using the method of the metachronous marking after receipt of the histology. To our knowledge, no study has proven this approach yet.<\/p>Thus, our purpose was to evaluate the feasibility and the accuracy of a subsequent marking of biopsy areas under ultrasound (US) guidance after receipt of histology of the ST-VABB of microcalcifications or mammographic masses which have not been detected by US.<\/p><h2>Materials and Methods<\/h2>The institutional ethics committee approved the study and granted a waiver of informed consent.<\/p><h3>Patients and Lesions<\/h3>All interventional procedures and examinations were performed at the institution of the senior author. Between 2009 and 2011, patients undergoing a ST-VABB received a metachronously inserted marker coil if there was no representative lesion left at the biopsy site and the histology warranted a further operation (B3–B5 lesions). In 2011, a nationwide quality agreement was brought into action that recommended a synchronous marker placement in these cases. In the patient documentation system (Orbis, Agfa Healthcare, Mortsel, Belgium), 98 consecutive patients who received a coil marking were documented. The interventional procedures were performed by the senior author with &gt;15 years of experience in breast imaging and interventions. Due to the following reasons, 52 patients were not included in our retrospective analysis: lost to follow-up, patient did not receive a ST-VABB, patient left the hospital, or patient received a magnetic resonance (MR)-guided biopsy. For reasons of data homogeneity, we focused on 45 women who received a ST-VABB procedure with a subsequent US-guided coil placement of 46 lesions\/biopsy areas (Table <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#T1\">1<\/u><\/a>).<\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(5).png\"><\/figure>All mammograms were performed using a phosphor storage digital mammography system (DMR+, General Electric, Boston, MA, USA; FCR PROFECT CS, FUJIFILM Corporation, Tokyo, Japan).<\/p><h3>Vacuum-Assisted Stereotactic Biopsy<\/h3>All biopsies were performed using a dedicated prone biopsy unit with digital imaging (Senovision, General Electric) and a vacuum-assisted biopsy system with a 10-gauge biopsy probe (Vacora, Bard Medical Division, Covington, GA, USA). Specimen radiography was done of all obtained probes. No tissue markers were deployed at the biopsy site. All specimens were sent to the in-house pathology in a usual 10% formalin solution.<\/p><h3>Coil Placement under Sonographic Guidance<\/h3>A Logic 9 sonographic unit (GE Healthcare, Boston, MA, USA) with 10- and 13-MHz linear transducers was used. Coil placement was done using a 4-mm MR-compatible metallic coil marker (MReye®, Cook Medical, Bloomington, IN, USA) (Fig. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#F1\">1<\/u><\/a>). After preparation of the intervention area, the coil introducer (19.5 G) was placed directly into the center of the biopsy cavity using US real-time guidance with a freehand technique and sterile US gel. During the procedure, the transducer was always placed at a minimum distance of 1 cm to the needle insertion site. The coil is about 2 cm long and acquires a spiral configuration with 4 mm diameter when placed. Subsequently, two-view mammograms were obtained to confirm deployment of the coil and to assess the accuracy of its location.<\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(7).png\"><\/figure><h3>Radiologic Evaluation and Statistical Analysis<\/h3>The direct method of measurement [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B6\">6<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B25\">25<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B26\">26<\/u><\/a>] was used to define the distance from the center of the lesion and the biopsy cavity to the clip in both planes. Statistical analysis was performed using dedicated software (BiAS version 11.0, Epsilon Verlag, Germany). The distances from the original lesion\/the coil to the nipple were measured. The delta values from the distance nipple–original lesion and from the distance nipple–coil were determined. All measurements were made with a precision under 1 mm, using the measuring tool which is available with the standard software package in AGFA IMPAX (AGFA HealthCare, Mortsel, Belgium). The Wilcoxon-Mann-Whitney test was used to test for any influence of the time interval between the ST-VABB and the coil placement under US guidance on the precision of the marker deployment. A p<\/i> value ≤0.05 was considered as statistically significant.<\/p><h2>Results<\/h2>The average age of the patients was 59.2 years (median 58, min. 45 and max. 87). The laterality distribution was as follows: 22 (47.8%) of the 46 lesions were right-sided and 24 (52.2%) were left-sided. The mammographic presentation was a mass in 6 (13%) and microcalcifications in 40 (87%) cases. Altogether, 56.5% of all lesions were classified as BI-RADS©<\/sup> category 4a, 21.7% as 4b, 19.6% as 4c, and 2.2% as 5 according to the classification of the American College of Radiology (BI-RADS 4th ed.). The distance of the lesion from the nipple ranged from 2.4 to 11.9 cm (mean 6.6 ± 2.3; median 6) in the craniocaudal (cc) view and from 2.3 to 10.9 cm (mean 6.5 ± 2.2; median 6) in the mediolateral (ml) view. The size of the lesions ranged from 0.5 to 2.5 cm. In 37 of 46 (80.4%) biopsies, 12 specimens were taken, in 7 (15.2%) biopsies 18 specimens, and in 2 (4.4%) biopsies 6 specimens. The postbiopsy\/preoperative histological diagnoses comprised of 11 (23.9%) B-3 lesions (4 cases with papillary findings, 2 with ADH, 3 with FEA, 1 with LN, and 1 with radial scar complex), 23 (50%) B-5a lesions (ductal carcinoma in situ), and 12 (26.1%) B-5b lesions (invasive ductal carcinoma\/invasive carcinoma of no special type).<\/p>The mean time between ST-VABB and sonographic marking was 9.7 ± 9.2 days (median 6.5 [range 2–52]). The mean time for the not instantly exact markings was 9.8 ± 3.9 days (median 11 [range 5–14]). The Wilcoxon-Mann-Whitney test showed no statistical difference (p<\/i> = 0.46) between the 2 groups (Fig. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#F2\">2<\/u><\/a>). The biopsy cavity could be detected by the interventionalist under US guidance in 40 (87%) of the 46 cases. A coil marker was used for every patient. The mean imaging time of the marking procedure was 12.5 min. The mammography after marking showed an exact placement of the coil in 40 cases.<\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(9).png\"><\/figure>Of the 46 US-guided markings, 6 were not precise (13%, 95% CI 5–26). Concerning the inexact markings, please see the data for the distances in Table <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#T2\">2<\/u><\/a>. In all 6 initially inexact markings, the biopsy site could be successfully marked in the second attempt.<\/span><\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(11).png\"><\/figure>The mean distance between the nipple and the coil was 6.9 ± 2.3 cm in the cc view and 6.7 ± 2.3 cm in the ml view for all cases. The mean distance between the coil and the target lesion was 0.6 ± 1.5 cm in the cc view and 0.5 ± 1.5 cm in the ml view for all lesions. For the instantly exact markings, the mean distance between the coil and the target lesion was 0.04 ± 0.2 cm (range 0–1.2) in the cc view and 0.04 ± 0.2 cm (range 0–1) in the ml view. The mean delta value from the distance nipple–original lesion and from the distance nipple–coil was 0.85 ± 1.2 cm (median 0.5) in the cc view and 0.88 ± 1.2 cm (median 0.6) in the ml view for all cases (Table <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#T3\">3<\/u><\/a>).<\/span><\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(13).png\"><\/figure>All interventions were technically successful and no complications occurred (Fig. <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#F3\">3<\/u><\/a>, <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#F4\">4<\/u><\/a>). In 87% of the 45 women who were biopsied due to suspect microcalcifications, 52.2% of the calcifications were removed completely and 47.8% incompletely. Solid masses (in 6 of 45 women) were removed completely in 60% and incompletely in 40%. All postoperative findings were in concordance with the preoperative histologies.<\/span><\/p><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(15).png\"><\/figure><figure class=\"image\"><img src=\"\/datafiles\/30494\/upload\/images\/2026-06\/image(16).png\"><\/figure><h2>Discussion<\/h2>The use of tissue markers is one of the keys for optimal patient management and allows the multidisciplinary team to synthesize the information gained from the different procedures [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B5\">5<\/u><\/a>]. According to Thomassin-Naggara et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B3\">3<\/u><\/a>], breast tissue markers should even be deployed after each percutaneous intervention. Efforts have been made to reduce costs with regard to clip marking [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B25\">25<\/u><\/a>] in a climate of increasingly restrictive reimbursement. As one drawback of marker placement, immediate and delayed migration of marker clips has been reported, though [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B16\">16<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B27\">27<\/u><\/a>]. A couple of attempts have been made to avoid clip migration and to improve the visibility of the tissue marker. Collagen-plug marking devices were developed to ensure that the marker is placed exactly into the biopsy cavity and “the accordion effect” is avoided [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B28\">28<\/u><\/a>]. In the literature, some attempts to explain clip migration, for example, as a part of radiographer technique can be found, especially with large breasts [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B2\">2<\/u><\/a>, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B12\">12<\/u><\/a>]. The question which remains is to which extent clip migration has to be tolerated as an unavoidable and unpredictable event and which breast features foster clip migration. So far, there are no guidelines on how to manage clip displacement [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B5\">5<\/u><\/a>].<\/p>A study from Uematsu et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B23\">23<\/u><\/a>] reports that breast thickness may play a role in clip migration, however, with thin breasts exhibiting a greater clip movement. Another group experienced that clip migration occurred in predominantly fatty breasts [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B8\">8<\/u><\/a>].<\/p>The coil we used provides a good visibility in all breast imaging modalities. It consists of a nickel-titanium alloy, which is well tolerated. Once the coil is released, it attaches to the wall of the biopsy site. Through secondary clip marking, migration of a clip by decompression could be avoided. In this study, we could not investigate if slow migration occurred, since every patient was operated.<\/p>Hematoma-directed ultrasound-guided lumpectomy was introduced in a publication by Arentz et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B29\">29<\/u><\/a>]. The hematoma which was created during the initial biopsy was used to localize the lesion either pre- or intraoperatively for excision. Since a hematoma is supposed to be absorbed after 2–5 weeks, this technique has its disadvantages in patients with neoadjuvant chemotherapy. Hence, our approach to mark the hematoma\/biopsy cavity a short time after proof of a relevant histology seems to be more reliable.<\/p>The same coil that was used in our study was placed by Sever et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B30\">30<\/u><\/a>] under US guidance into the tumor of patients prior to neoadjuvant chemotherapy. Speck et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B31\">31<\/u><\/a>] showed a stable localization of the coil after 1–9 months. In a study by Viehweg et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B32\">32<\/u><\/a>], US-guided clip marking was accomplished in patients with proven breast cancer under neoadjuvant chemotherapy, if there was a marked response under therapy.<\/p>There are only a few case reports which deal with allergic reactions to breast tissue markers. One noteworthy publication is that by Tamai et al. [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7768143\/#B33\">33<\/u><\/a>]. A patient with a history of atopic dermatitis was marked with titanium clips and experienced a severe exacerbation. Such allergic reactions might be very rare, but in the context of a potentially avoidable foreign body implantation relevant to mention.<\/p>Our study has several limitations. We did not involve a comparison group; the number of patients studied was relatively small; and this was a retrospective single-center study. A prospective 2-armed multi-institutional study comparing synchronous with metachronous marking of the biopsy site could overcome these drawbacks. By avoiding synchronous marking after every complete or incomplete resection of a lesion during an ST-VABB procedure, unnecessary clip marking could be avoided and reduced.<\/p>In conclusion, our study demonstrates the feasibility of metachronous coil marking of the stereotactic vacuum biopsy site under US guidance. The accuracy of the lesion localization proved to be high. No marker migration was seen using metachronous coil marking. This approach seems to be a cost-effective alternative to the standard procedure of primary coil marking in all completely removed lesions, particularly in allergic patients.<\/p><h2>Statement of Ethics<\/h2>The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The authors state that subjects (or their parents or guardians) have given their written informed consent. The study protocol was approved by the institute's committee on human research.<\/p><h2>Disclosure Statement<\/h2>Prof. Markus Müller-Schimpfle receives a royalty of Cook Medical, Bloomington, IN, USA, for the co-development of the MReye® breast localization coil. The other authors have no conflicts of interest to declare.<\/p><h2>Funding Sources<\/h2>The authors did not receive any funding for the study.<\/p><h2>Author Contributions<\/h2>C.P., D.L., B.K., T.J.V.: manuscript writing, statistical analysis. F.C., M.M.-S.: executors of the study, performers of the interventions. V.M., P.H., K.E., S.F.: literature research, critical analysis of the manuscript.<\/p><h2>Acknowledgement<\/h2>The authors acknowledge Prof. Markus Müller-Schimpfle's contributions to the research of this study.<\/p><h2>References<\/h2><ul><li>1.Liberman L, Dershaw DD, Morris EA, Abramson AF, Thornton CM, Rosen PP. Clip placement after stereotactic vacuum-assisted breast biopsy. Radiology. 1997 Nov;205((2)):417–22. doi: 10.1148\/radiology.205.2.9356622. [<a href=\"https:\/\/doi.org\/10.1148\/radiology.205.2.9356622\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9356622\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Clip%20placement%20after%20stereotactic%20vacuum-assisted%20breast%20biopsy&amp;author=L%20Liberman&amp;author=DD%20Dershaw&amp;author=EA%20Morris&amp;author=AF%20Abramson&amp;author=CM%20Thornton&amp;volume=205&amp;issue=(2)&amp;publication_year=1997&amp;pages=417-22&amp;pmid=9356622&amp;doi=10.1148\/radiology.205.2.9356622&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>2.Burbank F, Forcier N. Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization. Radiology. 1997 Nov;205((2)):407–15. doi: 10.1148\/radiology.205.2.9356621. [<a href=\"https:\/\/doi.org\/10.1148\/radiology.205.2.9356621\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9356621\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Tissue%20marking%20clip%20for%20stereotactic%20breast%20biopsy:%20initial%20placement%20accuracy,%20long-term%20stability,%20and%20usefulness%20as%20a%20guide%20for%20wire%20localization&amp;author=F%20Burbank&amp;author=N%20Forcier&amp;volume=205&amp;issue=(2)&amp;publication_year=1997&amp;pages=407-15&amp;pmid=9356621&amp;doi=10.1148\/radiology.205.2.9356621&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>3.Thomassin-Naggara I, Jalaguier-Coudray A, Chopier J, Tardivon A, Trop I. Current opinion on clip placement after breast biopsy: a survey of practising radiologists in France and Quebec. Clin Radiol. 2013 Jul;68((7)):e378–83. doi: 10.1016\/j.crad.2012.12.013. [<a href=\"https:\/\/doi.org\/10.1016\/j.crad.2012.12.013\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23522486\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Clin%20Radiol&amp;title=Current%20opinion%20on%20clip%20placement%20after%20breast%20biopsy:%20a%20survey%20of%20practising%20radiologists%20in%20France%20and%20Quebec&amp;author=I%20Thomassin-Naggara&amp;author=A%20Jalaguier-Coudray&amp;author=J%20Chopier&amp;author=A%20Tardivon&amp;author=I%20Trop&amp;volume=68&amp;issue=(7)&amp;publication_year=2013&amp;pages=e378-83&amp;pmid=23522486&amp;doi=10.1016\/j.crad.2012.12.013&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>4.Smathers RL. Marking the cavity site after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Feb;180((2)):355–6. doi: 10.2214\/ajr.180.2.1800355. [<a href=\"https:\/\/doi.org\/10.2214\/ajr.180.2.1800355\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12540433\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=Marking%20the%20cavity%20site%20after%20stereotactic%20core%20needle%20breast%20biopsy&amp;author=RL%20Smathers&amp;volume=180&amp;issue=(2)&amp;publication_year=2003&amp;pages=355-6&amp;pmid=12540433&amp;doi=10.2214\/ajr.180.2.1800355&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>5.Thomassin-Naggara I, Lalonde L, David J, Darai E, Uzan S, Trop I. A plea for the biopsy marker: how, why and why not clipping after breast biopsy? Breast Cancer Res Treat. 2012 Apr;132((3)):881–93. doi: 10.1007\/s10549-011-1847-x. [<a href=\"https:\/\/doi.org\/10.1007\/s10549-011-1847-x\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22042370\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=A%20plea%20for%20the%20biopsy%20marker:%20how,%20why%20and%20why%20not%20clipping%20after%20breast%20biopsy?&amp;author=I%20Thomassin-Naggara&amp;author=L%20Lalonde&amp;author=J%20David&amp;author=E%20Darai&amp;author=S%20Uzan&amp;volume=132&amp;issue=(3)&amp;publication_year=2012&amp;pages=881-93&amp;pmid=22042370&amp;doi=10.1007\/s10549-011-1847-x&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>6.Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology. 2001 Feb;218((2)):510–6. doi: 10.1148\/radiology.218.2.r01fe39510. [<a href=\"https:\/\/doi.org\/10.1148\/radiology.218.2.r01fe39510\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11161170\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Metallic%20clip%20deployment%20during%20stereotactic%20breast%20biopsy:%20retrospective%20analysis&amp;author=EL%20Rosen&amp;author=TT%20Vo&amp;volume=218&amp;issue=(2)&amp;publication_year=2001&amp;pages=510-6&amp;pmid=11161170&amp;doi=10.1148\/radiology.218.2.r01fe39510&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>7.Chaveron C, Bachelle F, Fauquet I, Rocourt N, Faivre-Pierret M, Ceugnart L. [Clip migration after stereotactic macrobiopsy and presurgical localization: technical considerations and tricks] J Radiol. 2009 Jan;90((1 Pt 1)):31–6. doi: 10.1016\/s0221-0363(09)70075-7. [<a href=\"https:\/\/doi.org\/10.1016\/s0221-0363(09)70075-7\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19182711\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Radiol&amp;title=[Clip%20migration%20after%20stereotactic%20macrobiopsy%20and%20presurgical%20localization:%20technical%20considerations%20and%20tricks]&amp;author=C%20Chaveron&amp;author=F%20Bachelle&amp;author=I%20Fauquet&amp;author=N%20Rocourt&amp;author=M%20Faivre-Pierret&amp;volume=90&amp;issue=(1%20Pt%201)&amp;publication_year=2009&amp;pages=31-6&amp;pmid=19182711&amp;doi=10.1016\/s0221-0363(09)70075-7&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>8.Philpotts LE, Lee CH. Clip migration after 11-gauge vacuum-assisted stereotactic biopsy: case report. Radiology. 2002 Mar;222((3)):794–6. doi: 10.1148\/radiol.2223011263. [<a href=\"https:\/\/doi.org\/10.1148\/radiol.2223011263\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11867803\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Clip%20migration%20after%2011-gauge%20vacuum-assisted%20stereotactic%20biopsy:%20case%20report&amp;author=LE%20Philpotts&amp;author=CH%20Lee&amp;volume=222&amp;issue=(3)&amp;publication_year=2002&amp;pages=794-6&amp;pmid=11867803&amp;doi=10.1148\/radiol.2223011263&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>9.Reynolds HE. Marker clip placement following directional, vacuum-assisted breast biopsy. Am Surg. 1999 Jan;65((1)):59–60. [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9915534\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am%20Surg&amp;title=Marker%20clip%20placement%20following%20directional,%20vacuum-assisted%20breast%20biopsy&amp;author=HE%20Reynolds&amp;volume=65&amp;issue=(1)&amp;publication_year=1999&amp;pages=59-60&amp;pmid=9915534&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>10.Reynolds HE, Lesnefsky MH, Jackson VP. Tumor marking before primary chemotherapy for breast cancer. AJR Am J Roentgenol. 1999 Oct;173((4)):919–20. doi: 10.2214\/ajr.173.4.10511148. [<a href=\"https:\/\/doi.org\/10.2214\/ajr.173.4.10511148\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10511148\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=Tumor%20marking%20before%20primary%20chemotherapy%20for%20breast%20cancer&amp;author=HE%20Reynolds&amp;author=MH%20Lesnefsky&amp;author=VP%20Jackson&amp;volume=173&amp;issue=(4)&amp;publication_year=1999&amp;pages=919-20&amp;pmid=10511148&amp;doi=10.2214\/ajr.173.4.10511148&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>11.Birdwell RL, Jackman RJ. Clip or marker migration 5-10 weeks after stereotactic 11-gauge vacuum-assisted breast biopsy: report of two cases. Radiology. 2003 Nov;229((2)):541–4. doi: 10.1148\/radiol.2292021594. [<a href=\"https:\/\/doi.org\/10.1148\/radiol.2292021594\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14595153\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Clip%20or%20marker%20migration%205-10%20weeks%20after%20stereotactic%2011-gauge%20vacuum-assisted%20breast%20biopsy:%20report%20of%20two%20cases&amp;author=RL%20Birdwell&amp;author=RJ%20Jackman&amp;volume=229&amp;issue=(2)&amp;publication_year=2003&amp;pages=541-4&amp;pmid=14595153&amp;doi=10.1148\/radiol.2292021594&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>12.Madeley CR, Kessell MA, Madeley CJ, Taylor DB, Wylie EJ. Radiographer technique: does it contribute to the question of clip migration? J Med Imaging Radiat Oncol. 2015 Oct;59((5)):564–70. doi: 10.1111\/1754-9485.12327. [<a href=\"https:\/\/doi.org\/10.1111\/1754-9485.12327\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26108860\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Med%20Imaging%20Radiat%20Oncol&amp;title=Radiographer%20technique:%20does%20it%20contribute%20to%20the%20question%20of%20clip%20migration?&amp;author=CR%20Madeley&amp;author=MA%20Kessell&amp;author=CJ%20Madeley&amp;author=DB%20Taylor&amp;author=EJ%20Wylie&amp;volume=59&amp;issue=(5)&amp;publication_year=2015&amp;pages=564-70&amp;pmid=26108860&amp;doi=10.1111\/1754-9485.12327&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>13.Burnside ES, Sohlich RE, Sickles EA. Movement of a biopsy-site marker clip after completion of stereotactic directional vacuum-assisted breast biopsy: case report. Radiology. 2001 Nov;221((2)):504–7. doi: 10.1148\/radiol.2212010565. [<a href=\"https:\/\/doi.org\/10.1148\/radiol.2212010565\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11687696\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Movement%20of%20a%20biopsy-site%20marker%20clip%20after%20completion%20of%20stereotactic%20directional%20vacuum-assisted%20breast%20biopsy:%20case%20report&amp;author=ES%20Burnside&amp;author=RE%20Sohlich&amp;author=EA%20Sickles&amp;volume=221&amp;issue=(2)&amp;publication_year=2001&amp;pages=504-7&amp;pmid=11687696&amp;doi=10.1148\/radiol.2212010565&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>14.Kass R, Kumar G, Klimberg VS, Kass L, Henry-Tillman R, Johnson A, et al. Clip migration in stereotactic biopsy. Am J Surg. 2002 Oct;184((4)):325–31. doi: 10.1016\/s0002-9610(02)00952-2. [<a href=\"https:\/\/doi.org\/10.1016\/s0002-9610(02)00952-2\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12383894\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am%20J%20Surg&amp;title=Clip%20migration%20in%20stereotactic%20biopsy&amp;author=R%20Kass&amp;author=G%20Kumar&amp;author=VS%20Klimberg&amp;author=L%20Kass&amp;author=R%20Henry-Tillman&amp;volume=184&amp;issue=(4)&amp;publication_year=2002&amp;pages=325-31&amp;pmid=12383894&amp;doi=10.1016\/s0002-9610(02)00952-2&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>15.Harris AT. Clip migration within 8 days of 11-gauge vacuum-assisted stereotactic breast biopsy: case report. Radiology. 2003 Aug;228((2)):552–4. doi: 10.1148\/radiol.2282020910. [<a href=\"https:\/\/doi.org\/10.1148\/radiol.2282020910\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12819332\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiology&amp;title=Clip%20migration%20within%208%20days%20of%2011-gauge%20vacuum-assisted%20stereotactic%20breast%20biopsy:%20case%20report&amp;author=AT%20Harris&amp;volume=228&amp;issue=(2)&amp;publication_year=2003&amp;pages=552-4&amp;pmid=12819332&amp;doi=10.1148\/radiol.2282020910&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>16.Esserman LE, Cura MA, DaCosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics. 2004 Jan-Feb;24((1)):147–56. doi: 10.1148\/rg.241035052. [<a href=\"https:\/\/doi.org\/10.1148\/rg.241035052\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14730043\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Radiographics&amp;title=Recognizing%20pitfalls%20in%20early%20and%20late%20migration%20of%20clip%20markers%20after%20imaging-guided%20directional%20vacuum-assisted%20biopsy&amp;author=LE%20Esserman&amp;author=MA%20Cura&amp;author=D%20DaCosta&amp;volume=24&amp;issue=(1)&amp;publication_year=2004&amp;pages=147-56&amp;pmid=14730043&amp;doi=10.1148\/rg.241035052&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>17.Parikh J. Clip migration within 15 days of 11-gauge vacuum-assisted stereotactic breast biopsy. AJR Am J Roentgenol. 2005 Mar;184((3 Suppl)):S43–6. doi: 10.2214\/ajr.184.3_supplement.01840s43. [<a href=\"https:\/\/doi.org\/10.2214\/ajr.184.3_supplement.01840s43\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15728018\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=Clip%20migration%20within%2015%20days%20of%2011-gauge%20vacuum-assisted%20stereotactic%20breast%20biopsy&amp;author=J%20Parikh&amp;volume=184&amp;issue=(3%20Suppl)&amp;publication_year=2005&amp;pages=S43-6&amp;pmid=15728018&amp;doi=10.2214\/ajr.184.3_supplement.01840s43&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>18.Parikh J. Ultrasound demonstration of clip migration to Skin within 6 weeks of 11-gauge vacuum-assisted stereotactic breast biopsy. Breast J. 2004 Nov-Dec;10((6)):539–42. doi: 10.1111\/j.1075-122X.2004.21580.x. [<a href=\"https:\/\/doi.org\/10.1111\/j.1075-122X.2004.21580.x\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15569213\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast%20J&amp;title=Ultrasound%20demonstration%20of%20clip%20migration%20to%20Skin%20within%206%20weeks%20of%2011-gauge%20vacuum-assisted%20stereotactic%20breast%20biopsy&amp;author=J%20Parikh&amp;volume=10&amp;issue=(6)&amp;publication_year=2004&amp;pages=539-42&amp;pmid=15569213&amp;doi=10.1111\/j.1075-122X.2004.21580.x&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>19.Parikh JR. Delayed migration of Gel Mark Ultra clip within 15 days of 11-gauge vacuum-assisted stereotactic breast biopsy. AJR Am J Roentgenol. 2005 Jul;185((1)):203–6. doi: 10.2214\/ajr.185.1.01850203. [<a href=\"https:\/\/doi.org\/10.2214\/ajr.185.1.01850203\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15972424\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=Delayed%20migration%20of%20Gel%20Mark%20Ultra%20clip%20within%2015%20days%20of%2011-gauge%20vacuum-assisted%20stereotactic%20breast%20biopsy&amp;author=JR%20Parikh&amp;volume=185&amp;issue=(1)&amp;publication_year=2005&amp;pages=203-6&amp;pmid=15972424&amp;doi=10.2214\/ajr.185.1.01850203&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>20.Bernaerts A, De Schepper A, Jr, Van Dam P, Pouillon M. Clip migration after vacuum-assisted stereotactic breast biopsy: a pitfall in preoperative wire localization. JBR-BTR. 2007 May-Jun;90((3)):172–5. [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17696084\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=JBR-BTR&amp;title=Clip%20migration%20after%20vacuum-assisted%20stereotactic%20breast%20biopsy:%20a%20pitfall%20in%20preoperative%20wire%20localization&amp;author=A%20Bernaerts&amp;author=A%20De%20Schepper&amp;author=P%20Van%20Dam&amp;author=M.%20Pouillon&amp;volume=90&amp;issue=(3)&amp;publication_year=2007&amp;pages=172-5&amp;pmid=17696084&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>21.Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, et al. Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer. Geburtshilfe Frauenheilkd. 2013 Nov;73((11)):1135–8. doi: 10.1055\/s-0033-1351086. [<a href=\"https:\/\/doi.org\/10.1055\/s-0033-1351086\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3862042\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24771900\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Geburtshilfe%20Frauenheilkd&amp;title=Evaluation%20of%20Newly%20Adapted%20Clip%20Marker%20System%20in%20Ultrasound-Guided%20Core%20Needle%20Biopsy%20for%20Suspicion%20of%20Breast%20Cancer&amp;author=R%20Schulz-Wendtland&amp;author=P%20Dankerl&amp;author=G%20Dilbat&amp;author=M%20Bani&amp;author=PA%20Fasching&amp;volume=73&amp;issue=(11)&amp;publication_year=2013&amp;pages=1135-8&amp;pmid=24771900&amp;doi=10.1055\/s-0033-1351086&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>22.Shin K, Caudle AS, Kuerer HM, Santiago L, Candelaria RP, Dogan B, et al. Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision. AJR Am J Roentgenol. 2016 Dec;207((6)):1372–9. doi: 10.2214\/AJR.16.16545. [<a href=\"https:\/\/doi.org\/10.2214\/AJR.16.16545\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27726422\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=Radiologic%20Mapping%20for%20Targeted%20Axillary%20Dissection:%20Needle%20Biopsy%20to%20Excision&amp;author=K%20Shin&amp;author=AS%20Caudle&amp;author=HM%20Kuerer&amp;author=L%20Santiago&amp;author=RP%20Candelaria&amp;volume=207&amp;issue=(6)&amp;publication_year=2016&amp;pages=1372-9&amp;pmid=27726422&amp;doi=10.2214\/AJR.16.16545&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>23.Uematsu T, Kasami M, Takahashi K, Watanabe J, Yamasaki S, Tanaka K, et al. Clip placement after an 11-gauge vacuum-assisted stereotactic breast biopsy: correlation between breast thickness and clip movement. Breast Cancer. 2012 Jan;19((1)):30–6. doi: 10.1007\/s12282-011-0252-y. [<a href=\"https:\/\/doi.org\/10.1007\/s12282-011-0252-y\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21274668\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast%20Cancer&amp;title=Clip%20placement%20after%20an%2011-gauge%20vacuum-assisted%20stereotactic%20breast%20biopsy:%20correlation%20between%20breast%20thickness%20and%20clip%20movement&amp;author=T%20Uematsu&amp;author=M%20Kasami&amp;author=K%20Takahashi&amp;author=J%20Watanabe&amp;author=S%20Yamasaki&amp;volume=19&amp;issue=(1)&amp;publication_year=2012&amp;pages=30-6&amp;pmid=21274668&amp;doi=10.1007\/s12282-011-0252-y&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>24.Venkataraman S, Dialani V, Gilmore HL, Mehta TS. Stereotactic core biopsy: comparison of 11 gauge with 8 gauge vacuum assisted breast biopsy. Eur J Radiol. 2012 Oct;81((10)):2613–9. doi: 10.1016\/j.ejrad.2011.10.027. [<a href=\"https:\/\/doi.org\/10.1016\/j.ejrad.2011.10.027\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22127375\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Eur%20J%20Radiol&amp;title=Stereotactic%20core%20biopsy:%20comparison%20of%2011%20gauge%20with%208%20gauge%20vacuum%20assisted%20breast%20biopsy&amp;author=S%20Venkataraman&amp;author=V%20Dialani&amp;author=HL%20Gilmore&amp;author=TS%20Mehta&amp;volume=81&amp;issue=(10)&amp;publication_year=2012&amp;pages=2613-9&amp;pmid=22127375&amp;doi=10.1016\/j.ejrad.2011.10.027&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>25.Margolin FR, Jacobs RP, Denny SR, Schrumpf JD. Clip placement after sonographically guided percutaneous breast biopsy. Breast J. 2003 May-Jun;9((3)):226–30. doi: 10.1046\/j.1524-4741.2003.09319.x. [<a href=\"https:\/\/doi.org\/10.1046\/j.1524-4741.2003.09319.x\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12752632\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast%20J&amp;title=Clip%20placement%20after%20sonographically%20guided%20percutaneous%20breast%20biopsy&amp;author=FR%20Margolin&amp;author=RP%20Jacobs&amp;author=SR%20Denny&amp;author=JD%20Schrumpf&amp;volume=9&amp;issue=(3)&amp;publication_year=2003&amp;pages=226-30&amp;pmid=12752632&amp;doi=10.1046\/j.1524-4741.2003.09319.x&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>26.Yatake H, Sawai Y, Nishi T, Nakano Y, Nishimae A, Katsuda T, et al. Accuracy assessment methods of tissue marker clip placement after 11-gauge vacuum-assisted stereotactic breast biopsy: comparison of measurements using direct and conventional methods. Breast Cancer. 2017 Jul;24((4)):593–600. doi: 10.1007\/s12282-016-0743-y. [<a href=\"https:\/\/doi.org\/10.1007\/s12282-016-0743-y\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27878446\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast%20Cancer&amp;title=Accuracy%20assessment%20methods%20of%20tissue%20marker%20clip%20placement%20after%2011-gauge%20vacuum-assisted%20stereotactic%20breast%20biopsy:%20comparison%20of%20measurements%20using%20direct%20and%20conventional%20methods&amp;author=H%20Yatake&amp;author=Y%20Sawai&amp;author=T%20Nishi&amp;author=Y%20Nakano&amp;author=A%20Nishimae&amp;volume=24&amp;issue=(4)&amp;publication_year=2017&amp;pages=593-600&amp;pmid=27878446&amp;doi=10.1007\/s12282-016-0743-y&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>27.Bourke AG, Peter P, Jose CL. The disappearing clip: an unusual complication in MRI biopsy. BMJ Case Reports. 2014 Aug;2014 doi: 10.1136\/bcr-2014-204092. [<a href=\"https:\/\/doi.org\/10.1136\/bcr-2014-204092\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4139558\/\">PMC free article<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25139917\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=BMJ%20Case%20Reports&amp;title=The%20disappearing%20clip:%20an%20unusual%20complication%20in%20MRI%20biopsy&amp;author=AG%20Bourke&amp;author=P%20Peter&amp;author=CL%20Jose&amp;volume=2014&amp;publication_year=2014&amp;pmid=25139917&amp;doi=10.1136\/bcr-2014-204092&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>28.Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Nov;181((5)):1295–9. doi: 10.2214\/ajr.181.5.1811295. [<a href=\"https:\/\/doi.org\/10.2214\/ajr.181.5.1811295\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14573422\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=AJR%20Am%20J%20Roentgenol&amp;title=Accuracy%20of%20a%20collagen-plug%20biopsy%20site%20marking%20device%20deployed%20after%20stereotactic%20core%20needle%20breast%20biopsy&amp;author=EL%20Rosen&amp;author=JA%20Baker&amp;author=MS%20Soo&amp;volume=181&amp;issue=(5)&amp;publication_year=2003&amp;pages=1295-9&amp;pmid=14573422&amp;doi=10.2214\/ajr.181.5.1811295&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>29.Arentz C, Baxter K, Boneti C, Henry-Tillman R, Westbrook K, Korourian S, et al. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol. 2010 Oct;17((S3 Suppl 3)):378–83. doi: 10.1245\/s10434-010-1230-x. [<a href=\"https:\/\/doi.org\/10.1245\/s10434-010-1230-x\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20853061\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Ann%20Surg%20Oncol&amp;title=Ten-year%20experience%20with%20hematoma-directed%20ultrasound-guided%20(HUG)%20breast%20lumpectomy&amp;author=C%20Arentz&amp;author=K%20Baxter&amp;author=C%20Boneti&amp;author=R%20Henry-Tillman&amp;author=K%20Westbrook&amp;volume=17&amp;issue=(S3%20Suppl%203)&amp;publication_year=2010&amp;pages=378-83&amp;pmid=20853061&amp;doi=10.1245\/s10434-010-1230-x&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>30.Sever AR, O'Brien ME, Humphreys S, Singh I, Jones SE, Jones PA. Radiopaque coil insertion into breast cancers prior to neoadjuvant chemotherapy. Breast. 2005 Apr;14((2)):108–17. doi: 10.1016\/j.breast.2004.08.008. [<a href=\"https:\/\/doi.org\/10.1016\/j.breast.2004.08.008\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15767180\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast&amp;title=Radiopaque%20coil%20insertion%20into%20breast%20cancers%20prior%20to%20neoadjuvant%20chemotherapy&amp;author=AR%20Sever&amp;author=ME%20O%27Brien&amp;author=S%20Humphreys&amp;author=I%20Singh&amp;author=SE%20Jones&amp;volume=14&amp;issue=(2)&amp;publication_year=2005&amp;pages=108-17&amp;pmid=15767180&amp;doi=10.1016\/j.breast.2004.08.008&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>31.Speck S, Baur A, Krainick-Strobel U, Claussen CD, Siegmann K. Markierung von Mammakarzinomen mittels Metallspiralen (Coils) – Längsschnittanalyse der Ortsständigkeit der Coils. Fortschr Röntgenstr. 2008;332((9)):180. [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Fortschr%20R%C3%B6ntgenstr&amp;title=Markierung%20von%20Mammakarzinomen%20mittels%20Metallspiralen%20(Coils)%20%E2%80%93%20L%C3%A4ngsschnittanalyse%20der%20Ortsst%C3%A4ndigkeit%20der%20Coils&amp;author=S%20Speck&amp;author=A%20Baur&amp;author=U%20Krainick-Strobel&amp;author=CD%20Claussen&amp;author=K%20Siegmann&amp;volume=332&amp;issue=(9)&amp;publication_year=2008&amp;pages=180&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>32.Viehweg P, Fabel K, Petzold A, Friedrich K, Laniado M. [O-Twist Marker for marking breast cancer under neoadjuvant chemotherapy—first results] RoFo Fortschr Geb Rontgenstr Nuklearmed. 2007 Oct;179((10)):1055–60. doi: 10.1055\/s-2007-963193. [<a href=\"https:\/\/doi.org\/10.1055\/s-2007-963193\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17594630\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=RoFo%20Fortschr%20Geb%20Rontgenstr%20Nuklearmed&amp;title=[O-Twist%20Marker%20for%20marking%20breast%20cancer%20under%20neoadjuvant%20chemotherapy%E2%80%94first%20results]&amp;author=P%20Viehweg&amp;author=K%20Fabel&amp;author=A%20Petzold&amp;author=K%20Friedrich&amp;author=M%20Laniado&amp;volume=179&amp;issue=(10)&amp;publication_year=2007&amp;pages=1055-60&amp;pmid=17594630&amp;doi=10.1055\/s-2007-963193&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><li>33.Tamai K, Mitsumori M, Fujishiro S, Kokubo M, Ooya N, Nagata Y, et al. A case of allergic reaction to surgical metal clips inserted for postoperative boost irradiation in a patient undergoing breast-conserving therapy. Breast Cancer. 2001;8((1)):90–2. doi: 10.1007\/BF02967485. [<a href=\"https:\/\/doi.org\/10.1007\/BF02967485\" target=\"_blank\" rel=\"noopener noreferrer\">DOI<\/u><\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11180773\/\">PubMed<\/u><\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Breast%20Cancer&amp;title=A%20case%20of%20allergic%20reaction%20to%20surgical%20metal%20clips%20inserted%20for%20postoperative%20boost%20irradiation%20in%20a%20patient%20undergoing%20breast-conserving%20therapy&amp;author=K%20Tamai&amp;author=M%20Mitsumori&amp;author=S%20Fujishiro&amp;author=M%20Kokubo&amp;author=N%20Ooya&amp;volume=8&amp;issue=(1)&amp;publication_year=2001&amp;pages=90-2&amp;pmid=11180773&amp;doi=10.1007\/BF02967485&amp;\" target=\"_blank\" rel=\"noopener noreferrer\">Google Scholar<\/u><\/a>]<\/li><\/ul>","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/Bao-cao-lam-sang-dinh-vi-tuyen-vu-coil-marker.png?t=1780826523","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/Bao-cao-lam-sang-dinh-vi-tuyen-vu-coil-marker.png?t=1788692725","tags":["VABB","định vị tổn thương vú"],"count_view":311,"seo_name":"clinical-report-on-coil-marker-using-ultrasound-guidance-of-vacuum-assisted-breast-biopsy","date_update":1780824780,"date_created_format":1780826589,"meta_title":"Clinical Report: Ultrasound-Guided Breast Biopsy Marking","meta_desc":"Review clinical reports on vacuum-guided breast biopsy marking techniques under ultrasound guidance. Evaluate the feasibility and efficacy of this novel technique.","meta_keyword":"Marking of breast biopsy site,vacuumassisted breast biopsy,localization of breast lesion,radiotherapy,clinical report","qr_code":"https:\/\/psgmedical.com\/clinical-report-on-coil-marker-using-ultrasound-guidance-of-vacuum-assisted-breast-biopsy"},{"id":747172,"name":"WHAT IS A VISICOIL FIDUCIAL MARKER?","desc":"Visicoil Marker: The Standard in Tumor Localization and Accurate Radiotherapy Support<\/strong><\/p>In the modern era of radiotherapy, accuracy is a vital factor determining the success of a treatment regimen. Visicoil markers emerged as an essential solution, helping doctors and technicians optimize tumor localization, thereby improving treatment effectiveness and minimizing damage to surrounding healthy tissues.<\/p>","content":"1. Product Description<\/strong> Visicoil markers are spiral-shaped implantable markers specially designed from highly biocompatible materials (usually gold). This unique spiral structure not only provides optimal stability when implanted in body tissue but also offers superior visibility on modern diagnostic imaging systems such as CT, MRI, and ultrasound.<\/p>2. Technical Features<\/strong> Multimodal Visibility: Thanks to its high radiopacity, Visicoil ensures clear images with minimal artifact, allowing doctors to easily locate tumors even in complex imaging environments.<\/p>Biological Adhesion: The coil design ensures the marker remains firmly anchored at the target site, minimizing the risk of displacement over time – a common problem with traditional granular markers.<\/p>Flexibility: Easily compatible with various tumor sizes and locations, providing maximum clinical flexibility.<\/p>3. Purpose of Use<\/strong> Visicoil markers are indicated for use in pre-radiation procedures, with the main purposes of:<\/p>Accurately marking the tumor location or lesion boundaries before radiotherapy.<\/p>Supporting radiotherapy planning by providing reliable spatial landmarks.<\/p>Guiding daily image-guided radiotherapy (IGRT), ensuring the radiation beam remains precisely focused on the target tumor throughout treatment.<\/p>4. Clinical Results<\/strong> The application of Visicoil markers in treatment procedures offers outstanding value:<\/p>Absolute accuracy: Minimizes errors in tumor localization, allowing physicians to focus the highest radiation dose on the target.<\/p>Protecting healthy tissue: Accurate localization minimizes radiation dose to surrounding organs and healthy tissues, thereby reducing the rate of complications and side effects for patients.<\/p>Optimizing treatment protocols: Enabling physicians to confidently narrow the irradiation margin, improving local tumor control.<\/p>Enhancing patient experience: Thanks to stable and accurate localization procedures, patients feel more confident in the quality of treatment and minimize unnecessary risks.<\/p>","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/ilumark-visicoil-mr-fiducial-marker-straightcoilGold_bw.png?t=1761321640","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/ilumark-visicoil-mr-fiducial-marker-straightcoilGold_bw.png?t=1788692725","tags":["Radiotherapy","Medical devices","Tumor localization"],"count_view":332,"seo_name":"what-is-a-visicoil-fiducial-marker","date_update":1780823760,"date_created_format":1780824385,"meta_title":"Visicoil Marker: A Solution for Precisely Tumors for Radiotherapy","meta_desc":"Visicoil marker is a high-end, spiral-shaped tumor locator that supports precise radiotherapy, minimizes displacement, and protects healthy tissue. Learn more about the solution now!","meta_keyword":"IGRT,Visicoil marker,tumor locator,radiotherapy marker,preoperative positioning device,precision radiotherapy","qr_code":"https:\/\/psgmedical.com\/what-is-a-visicoil-fiducial-marker"},{"id":714297,"name":"4 key notes before doing IVF","desc":"","content":"1. Examination and assessment of reproductive health<\/strong><\/p>\n\nGeneral examination: cardiovascular, blood pressure, endocrine, chronic diseases (diabetes, thyroid, liver, kidney).<\/p>\n\nGynecological &amp; andrological examination: evaluation of uterus, ovaries, semen analysis.<\/p>\n\nRequired tests: HIV, hepatitis B\/C, syphilis, rubella, AMH (ovarian reserve), hormones, blood count.<\/p>\n\nUterine-ovarian ultrasound: detect fibroids, polyps, uterine adhesions, polycystic ovaries...<\/p>\n\nIf there is a disease, it needs to be treated and stabilized before starting IVF.<\/p>\n\n2. Prepare your lifestyle &amp; spirit<\/strong><\/p>\n\nNutrition:<\/p>\n\nEat lots of green vegetables, fruits, foods rich in protein and Omega-3 fatty acids (salmon, chia seeds, walnuts...).<\/p>\n\nSupplement folic acid, vitamin D, zinc, iron as prescribed by your doctor.<\/p>\n\nLifestyle habits:<\/p>\n\nGet enough sleep, avoid stress.<\/p>\n\nStop drinking, smoking, high doses of caffeine.<\/p>\n\nDo light exercise (yoga, walking).<\/p>\n\nPrepare mentally: IVF is a long journey, which may require many cycles. Couples should be mentally and financially united, ready to face the possibility of not being successful the first time.<\/p>\n\n3. Notes on medication and treatment<\/strong><\/p>\n\nStop or change the medication you are taking (if any): blood pressure medication, anticoagulants, hormones, antibiotics... need to consult a doctor.<\/p>\n\nVaccination: rubella, chickenpox, hepatitis B (if not immune).<\/p>\n\nControl weight: ideal BMI (18.5&ndash;23), avoid obesity because it can affect the results.<\/p>\n\nFor men: limit alcohol, high temperatures (hot baths, saunas), supplement zinc and vitamins to improve sperm.<\/p>\n\n4. Understand the process and prepare finances<\/strong><\/p>\n\nIVF steps: ovarian stimulation &rarr; egg retrieval &rarr; embryo fertilization &rarr; embryo culture &rarr; embryo transfer &rarr; pregnancy monitoring.<\/p>\n\nCost: usually 60&ndash;120 million\/time (excluding embryo freezing, special drugs, PGT\/PGS if any).<\/p>\n\nTime: 2&ndash;6 weeks\/cycle depending on the protocol.<\/p>\n\nPossible complications: ovarian hyperstimulation syndrome (OHSS), multiple pregnancies, miscarriage, ectopic pregnancy, etc.<\/p>\n\nSuccess rate: depends on age, reproductive health, protocol, IVF center.<\/p>\n\n✅ In summary<\/strong>: Before performing IVF, it is necessary to prepare physical and mental health, a healthy lifestyle and full knowledge of the process. This helps increase the chance of success and reduce risks.<\/p>\n","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/1715886586901.jpg?t=1756894190","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/1715886586901.jpg?t=1788692725","tags":["cacluuykhithuchienivf"],"count_view":367,"seo_name":"4-key-notes-before-doing-ivf","date_update":1757257740,"date_created_format":1757258105,"meta_title":"#cacluuykhithuchienivf","meta_desc":"#cacluuykhithuchienivf","meta_keyword":"cacluuykhithuchienivf","qr_code":"https:\/\/psgmedical.com\/4-key-notes-before-doing-ivf"},{"id":714238,"name":"Notes on choosing an embryo transfer catheter","desc":"<h1 data-end=\"329\" data-start=\"244\">???? Notes on choosing an embryo transfer catheter in IVF: A clinical practice perspective<\/span> \n1. Introduction<\/span> \nEmbryo transfer (ET) is a decisive step in the in vitro fertilization (IVF) process. Even with high-quality embryos and favorable endometrium, the final outcome can still be significantly affected by the embryo transfer technique and instruments. In particular, the embryo transfer catheter plays a central role: a suitable catheter helps reduce endometrial trauma, ensures optimal embryo placement, and improves implantation rates.<\/span><\/h1>\n","content":"2. Factors to consider when choosing a catheter<\/p>\n\n2.1. Soft-hard characteristics<\/p>\n\nSoft catheter<\/p>\n\nReduces the risk of damage to the endometrium and uterine contraction reflex.<\/p>\n\nThe preferred choice in most clinical cases.<\/p>\n\nRigid catheter<\/p>\n\nConvenient in cases where the cervix is bent and difficult to access.<\/p>\n\nHigher risk of trauma.<\/p>\n\nOptimal solution: prepare a &ldquo;dual system&rdquo; catheter (hard outer sheath for guidance + soft inner catheter for embryo placement).<\/p>\n\n2.2. Catheter tip design<\/p>\n\nSmooth tip, thin bevel, small diameter helps reduce trauma.<\/p>\n\nThe curved type is useful in patients with special uterine anatomy (anterior or posterior bend).<\/p>\n\n2.3. Ultrasound visibility (Echogenic tip)<\/p>\n\nCatheters with echogenic tips improve the accuracy of embryo transfer under ultrasound guidance.<\/p>\n\nHFEA (UK) recommends the use of ultrasound in ET because it is associated with a higher clinical pregnancy rate than &ldquo;blind&rdquo; embryo transfer.<\/p>\n\n2.4. Materials<\/p>\n\nPreferably bioinert materials (FEP &ndash; Fluoroethylene propylene, PU &ndash; Medical Polyurethane).<\/p>\n\nNo release of additives, no impact on embryo microenvironment.<\/p>\n\nNeed to ensure atraumatic (non-toxic, non-inflammatory).<\/p>\n\n2.5. Length &amp; scale<\/p>\n\nUsually 23&ndash;25 cm, suitable for most patients.<\/p>\n\nCatheter with cm scale helps the doctor control the depth into the uterine cavity.<\/p>\n\n2.6. Flexibility &amp; manipulation<\/p>\n\nSingle lumen: simple, fast, suitable for easy cases.<\/p>\n\nDouble lumen: has a guiding sheath, useful in difficult cervical cases or requiring multiple manipulations.<\/p>\n\n2.7. Quality &amp; Sterility Standards<\/p>\n\nInstruments must meet CE, FDA standards.<\/p>\n\nDisposable, sterile packaging, ensuring maximum safety.<\/p>\n\n3. Clinical evidence regarding embryo transfer catheters<\/p>\n\nStudies have shown that ease of use and non-traumatic ET are directly associated with higher success rates.<\/p>\n\nFlexible catheters have been shown to result in higher clinical pregnancy rates than rigid catheters in most reports (Mansour RT et al., Hum Reprod Update, 2011).<\/p>\n\nESHRE guidelines recommend the use of flexible catheters, with ultrasound-enabled tips, and performing embryo transfer under ultrasound guidance when possible.<\/p>\n\n4. Conclusion<\/p>\n\nChoosing an embryo transfer catheter is not only a technical issue but also a decisive factor in the success rate of IVF. Doctors need to consider:<\/p>\n\nThe softness and design of the catheter tip,<\/p>\n\nUltrasound visibility,<\/p>\n\nThe biosafety of the material,<\/p>\n\nThe flexibility in clinical operations.<\/p>\n\nAn optimally designed catheter will help the embryo transfer process to be gentle, less traumatic, place the embryo in the right position and thereby improve the chance of pregnancy.<\/p>\n","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/35.png?t=1757185213","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/35.png?t=1788692725","tags":["catheter catheterchuyenphoi catheterIUI"],"count_view":424,"seo_name":"notes-on-choosing-an-embryo-transfer-catheter","date_update":1757184360,"date_created_format":1757185005,"meta_title":"Lựa chọn catheter như thế nào","meta_desc":"","meta_keyword":"catheter catheterchuyenphoi catheterIUI","qr_code":"https:\/\/psgmedical.com\/notes-on-choosing-an-embryo-transfer-catheter"},{"id":530281,"name":"LẠC NỘI MẠC TỬ CUNG.","desc":"<h2 class=\"css-13i30ag\" style=\"margin-bottom:15px; margin-top:0px; padding-top:0px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"What-is-endometriosis?\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Lạc nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/a><\/span><\/span><\/div>\n\nLạc nội mạc tử cung l&agrave; một rối loạn trong đ&oacute; c&aacute;c m&ocirc; tương tự như ni&ecirc;m mạc tử cung ph&aacute;t triển b&ecirc;n ngo&agrave;i khoang tử cung của bạn.&nbsp;<\/font>Nội mạc tử cung của bạn được gọi l&agrave; nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n","content":"<a class=\"chartbeat-section\" name=\"What-is-endometriosis?\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:38px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:700; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">Lạc nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/a><\/p>\n\nLạc nội mạc tử cung l&agrave; một rối loạn trong đ&oacute; c&aacute;c m&ocirc; tương tự như ni&ecirc;m mạc tử cung ph&aacute;t triển b&ecirc;n ngo&agrave;i khoang tử cung của bạn.&nbsp;<\/font>Nội mạc tử cung của bạn được gọi l&agrave; nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nLạc nội mạc tử cung xảy ra khi c&aacute;c m&ocirc; giống nội mạc tử cung ph&aacute;t triển tr&ecirc;n buồng trứng, ruột v&agrave; c&aacute;c m&ocirc; l&oacute;t trong khung chậu của bạn.&nbsp;<\/font>Rất hiếm khi m&ocirc; giống nội mạc tử cung lan ra ngo&agrave;i v&ugrave;ng chậu của bạn, nhưng kh&ocirc;ng phải l&agrave; kh&ocirc;ng thể.&nbsp;<\/font>M&ocirc; giống nội mạc tử cung ph&aacute;t triển b&ecirc;n ngo&agrave;i tử cung của bạn được gọi l&agrave; m&ocirc; cấy gh&eacute;p nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nSự thay đổi nội tiết tố của chu kỳ kinh nguyệt của bạn ảnh hưởng đến c&aacute;c m&ocirc; giống như nội mạc tử cung bị lạc chỗ, khiến khu vực n&agrave;y bị vi&ecirc;m v&agrave; đau.&nbsp;<\/font>Điều n&agrave;y c&oacute; nghĩa l&agrave; m&ocirc; sẽ ph&aacute;t triển, d&agrave;y l&ecirc;n v&agrave; ph&acirc;n hủy.&nbsp;<\/font>Theo thời gian, c&aacute;c m&ocirc; bị ph&acirc;n hủy sẽ kh&ocirc;ng thể đi hết v&agrave; bị mắc kẹt trong xương chậu của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nM&ocirc; n&agrave;y bị mắc kẹt trong xương chậu của bạn c&oacute; thể g&acirc;y ra:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;); color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">k&iacute;ch th&iacute;ch<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">Sự h&igrave;nh th&agrave;nh sẹo<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">kết d&iacute;nh, trong đ&oacute; m&ocirc; li&ecirc;n kết c&aacute;c cơ quan v&ugrave;ng chậu của bạn với nhau<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">đau dữ dội xảy ra trong chu kỳ kinh nguyệt<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">vấn đề sinh sản<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"chartbeat-section\" name=\"symptoms\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; outline-width:0px; color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:38px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:700; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">C&aacute;c triệu chứng lạc nội mạc tử cung<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tC&aacute;c triệu chứng của lạc nội mạc tử cung kh&aacute;c nhau.&nbsp;<\/font>Một số người gặp c&aacute;c triệu chứng nhẹ, nhưng những người kh&aacute;c c&oacute; thể c&oacute; c&aacute;c triệu chứng trung b&igrave;nh đến nặng.&nbsp;<\/font>Mức độ nghi&ecirc;m trọng của cơn đau kh&ocirc;ng cho biết mức độ hoặc giai đoạn của t&igrave;nh trạng.&nbsp;<\/font>Bạn c&oacute; thể bị một dạng nhẹ của bệnh nhưng cảm thấy đau đớn tột c&ugrave;ng.&nbsp;<\/font>Cũng c&oacute; thể c&oacute; dạng nặng v&agrave; rất &iacute;t kh&oacute; chịu.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tĐiều quan trọng cần lưu &yacute; l&agrave; bạn c&oacute; thể kh&ocirc;ng gặp bất kỳ triệu chứng n&agrave;o.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tĐau v&ugrave;ng chậu l&agrave; triệu chứng phổ biến nhất của bệnh lạc nội mạc tử cung.&nbsp;<\/font>Bạn cũng c&oacute; thể c&oacute; c&aacute;c triệu chứng sau:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/painful-menstrual-periods\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">thời kỳ đau đớn<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">chuột r&uacute;t 1 hoặc 2 tuần xung quanh kỳ kinh nguyệt<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/menstrual-periods-heavy-prolonged-or-irregular\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">chảy m&aacute;u kinh nguyệt nhiều<\/font><\/font><\/a>&nbsp;hoặc chảy m&aacute;u giữa c&aacute;c kỳ kinh<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/infertility\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">kh&ocirc; khan<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/dyspareunia\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">đau khi quan hệ t&igrave;nh dục<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">kh&oacute; chịu khi đi ti&ecirc;u<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">đau lưng dưới c&oacute; thể xảy ra bất cứ l&uacute;c n&agrave;o trong chu kỳ kinh nguyệt của bạn<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tĐiều quan trọng l&agrave; bạn phải kh&aacute;m phụ khoa thường xuy&ecirc;n, điều n&agrave;y sẽ cho ph&eacute;p b&aacute;c sĩ phụ khoa của bạn theo d&otilde;i bất kỳ thay đổi n&agrave;o.&nbsp;<\/font>Điều n&agrave;y đặc biệt quan trọng nếu bạn c&oacute; hai hoặc nhiều triệu chứng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t<a class=\"chartbeat-section\" name=\"treatment\" style=\"color: rgb(35, 31, 32); background-color: rgb(255, 255, 255); -webkit-font-smoothing: antialiased; box-sizing: inherit; font-size: 38px; font-weight: 700;\">Điều trị lạc nội mạc tử cung<\/font><\/font><\/a><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t&nbsp;<\/p>\n\n\tN&oacute;i một c&aacute;ch dễ hiểu, bạn muốn giảm đau nhanh ch&oacute;ng v&agrave; c&aacute;c triệu chứng kh&aacute;c của bệnh lạc nội mạc tử cung.&nbsp;<\/font>T&igrave;nh trạng n&agrave;y c&oacute; thể g&acirc;y ra những th&aacute;ch thức trong c&aacute;c hoạt động h&agrave;ng ng&agrave;y của bạn nếu kh&ocirc;ng được điều trị.&nbsp;<\/font>Lạc nội mạc tử cung kh&ocirc;ng c&oacute; c&aacute;ch chữa trị, nhưng c&aacute;c triệu chứng của n&oacute; c&oacute; thể được kiểm so&aacute;t.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tC&aacute;c lựa chọn y tế v&agrave; phẫu thuật c&oacute; sẵn để gi&uacute;p giảm c&aacute;c triệu chứng của bạn v&agrave; kiểm so&aacute;t mọi biến chứng tiềm ẩn.&nbsp;<\/font>Trước ti&ecirc;n, b&aacute;c sĩ c&oacute; thể thử c&aacute;c phương ph&aacute;p điều trị bảo tồn.&nbsp;<\/font>Sau đ&oacute;, họ c&oacute; thể đề nghị phẫu thuật nếu t&igrave;nh trạng của bạn kh&ocirc;ng cải thiện.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMọi người phản ứng kh&aacute;c nhau với c&aacute;c lựa chọn điều trị n&agrave;y.&nbsp;<\/font>B&aacute;c sĩ sẽ gi&uacute;p bạn t&igrave;m ra loại ph&ugrave; hợp nhất với bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tC&aacute;c lựa chọn điều trị bao gồm:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Thuốc giảm đau<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tBạn c&oacute; thể thử d&ugrave;ng thuốc giảm đau kh&ocirc;ng k&ecirc; đơn như ibuprofen nhưng lưu &yacute; rằng ch&uacute;ng kh&ocirc;ng hiệu quả trong mọi trường hợp.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Liệu ph&aacute;p hormone<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tD&ugrave;ng nội tiết tố bổ sung đ&ocirc;i khi c&oacute; thể l&agrave;m giảm đau v&agrave; ngăn chặn sự tiến triển của lạc nội mạc tử cung.&nbsp;<\/font>Liệu ph&aacute;p hormone gi&uacute;p cơ thể bạn điều chỉnh sự thay đổi hormone h&agrave;ng th&aacute;ng để th&uacute;c đẩy sự ph&aacute;t triển của c&aacute;c m&ocirc; xảy ra với bệnh lạc nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Thuốc tr&aacute;nh thai nội tiết<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tThuốc tr&aacute;nh thai nội tiết l&agrave;m giảm khả năng sinh sản bằng c&aacute;ch ngăn chặn sự ph&aacute;t triển v&agrave; t&iacute;ch tụ h&agrave;ng th&aacute;ng của c&aacute;c m&ocirc; giống nội mạc tử cung.&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/birth-control-pills\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">Thuốc tr&aacute;nh thai<\/font><\/font><\/a>&nbsp;,&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/birth-control\/birth-control-patch\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">miếng d&aacute;n<\/font><\/font><\/a>&nbsp;v&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/birth-control-vaginal-ring\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">v&ograve;ng &acirc;m đạo<\/font><\/font><\/a>&nbsp;c&oacute; thể l&agrave;m giảm hoặc thậm ch&iacute; loại bỏ cơn đau trong trường hợp lạc nội mạc tử cung &iacute;t nghi&ecirc;m trọng hơn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tThuốc ti&ecirc;m medroxyprogesterone (Depo-Provera) cũng c&oacute; hiệu quả trong việc ngừng kinh nguyệt.&nbsp;<\/font>N&oacute; ngăn chặn sự ph&aacute;t triển của cấy gh&eacute;p nội mạc tử cung.&nbsp;<\/font>N&oacute; l&agrave;m giảm đau v&agrave; c&aacute;c triệu chứng kh&aacute;c.&nbsp;<\/font>Tuy nhi&ecirc;n, đ&acirc;y c&oacute; thể kh&ocirc;ng phải l&agrave; lựa chọn đầu ti&ecirc;n của bạn v&igrave; nguy cơ tăng c&acirc;n, giảm sản xuất xương v&agrave; tăng tỷ lệ trầm cảm trong một số trường hợp.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Chất chủ vận v&agrave; chất đối kh&aacute;ng hormone giải ph&oacute;ng gonadotropin (GnRH)<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tMọi người sử dụng c&aacute;i được gọi l&agrave; chất chủ vận v&agrave; chất đối kh&aacute;ng giải ph&oacute;ng hormone gonadotropin (GnRH) để ngăn chặn việc sản xuất estrogen k&iacute;ch th&iacute;ch buồng trứng.&nbsp;<\/font>Một v&iacute; dụ về chất chủ vận GnRH l&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.medicalnewstoday.com\/articles\/lupron-depot\" rel=\"noopener noreferrer nofollow\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">Lupron Depot<\/font><\/font><\/a>&nbsp;, thuốc ti&ecirc;m, trong khi&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa1700089\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">Elagolix<\/font><\/font><\/a>&nbsp;, d&ugrave;ng đường uống, l&agrave; chất đối kh&aacute;ng.&nbsp;<\/font>Cả hai đều c&oacute; thể ngăn chặn sản xuất estrogen.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/womens-health\/benefits-of-estrogen\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">Estrogen<\/font><\/font><\/a>&nbsp;l&agrave; hormone chịu tr&aacute;ch nhiệm ch&iacute;nh cho sự ph&aacute;t triển c&aacute;c đặc điểm giới t&iacute;nh ở những người được chỉ định l&agrave; nữ khi sinh.&nbsp;<\/font>Việc ngăn chặn sản xuất estrogen sẽ ngăn cản kinh nguyệt v&agrave; tạo ra thời kỳ m&atilde;n kinh nh&acirc;n tạo.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tLiệu ph&aacute;p GnRH c&oacute; c&aacute;c t&aacute;c dụng phụ như kh&ocirc; &acirc;m đạo v&agrave; bốc hỏa.&nbsp;<\/font>D&ugrave;ng liều lượng nhỏ estrogen v&agrave; progesterone c&ugrave;ng l&uacute;c c&oacute; thể gi&uacute;p hạn chế hoặc ngăn ngừa c&aacute;c triệu chứng n&agrave;y.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tViệc chẩn đo&aacute;n v&agrave; bắt đầu c&aacute;c lựa chọn điều trị sớm khi mắc bệnh c&oacute; thể l&agrave; một th&aacute;ch thức.&nbsp;<\/font>Suy nghĩ về - hoặc đương đầu với - c&aacute;c triệu chứng như c&aacute;c vấn đề về khả năng sinh sản v&agrave; đau đớn c&ugrave;ng với nỗi sợ h&atilde;i c&oacute; thể khiến bạn giảm bớt căng thẳng c&oacute; thể g&acirc;y căng thẳng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tĐiều quan trọng l&agrave; phải giải quyết vấn đề sức khỏe tinh thần của bạn như một phần của sức khỏe tổng thể của bạn.&nbsp;<\/font>C&acirc;n nhắc t&igrave;m một nh&oacute;m hỗ trợ v&agrave; gi&aacute;o dục bản th&acirc;n nhiều hơn về t&igrave;nh trạng bệnh.&nbsp;<\/font>Thực hiện c&aacute;c bước n&agrave;y c&oacute; thể hữu &iacute;ch trong việc tạo ra một c&aacute;ch tiếp cận c&acirc;n bằng để quản l&yacute; t&igrave;nh trạng của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Danazol<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tDanazol l&agrave; một loại thuốc kh&aacute;c được sử dụng để ngừng kinh nguyệt v&agrave; gi&uacute;p giảm c&aacute;c triệu chứng của bệnh lạc nội mạc tử cung.&nbsp;<\/font>Trong khi d&ugrave;ng danazol, bệnh c&oacute; thể tiếp tục tiến triển.&nbsp;<\/font>Danazol c&oacute; thể g&acirc;y ra c&aacute;c t&aacute;c dụng phụ, bao gồm&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/skin\/acne\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">mụn trứng c&aacute;<\/font><\/font><\/a>&nbsp;v&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/excessive-or-unwanted-hair-in-women\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">rậm l&ocirc;ng<\/font><\/font><\/a>&nbsp;.&nbsp;<\/font>Rậm l&ocirc;ng l&agrave; t&igrave;nh trạng l&ocirc;ng mọc qu&aacute; nhiều tr&ecirc;n mặt v&agrave; cơ thể.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tC&aacute;c loại thuốc kh&aacute;c đang được nghi&ecirc;n cứu c&oacute; thể cải thiện c&aacute;c triệu chứng v&agrave; l&agrave;m chậm sự tiến triển của bệnh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Phẫu thuật bảo tồn<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tPhẫu thuật bảo tồn thường được &aacute;p dụng cho những người muốn mang thai hoặc những người bị đau dữ dội v&agrave; c&aacute;c phương ph&aacute;p điều trị bằng nội tiết tố kh&ocirc;ng c&oacute; t&aacute;c dụng.&nbsp;<\/font>Mục ti&ecirc;u của phẫu thuật bảo tồn l&agrave; loại bỏ hoặc ph&aacute; hủy c&aacute;c khối nội mạc tử cung m&agrave; kh&ocirc;ng l&agrave;m tổn thương cơ quan sinh sản.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/gynecologic-laparoscopy\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">Nội soi ổ bụng<\/font><\/font><\/a>&nbsp;, một phẫu thuật x&acirc;m lấn tối thiểu, được sử dụng để h&igrave;nh dung v&agrave; chẩn đo&aacute;n lạc nội mạc tử cung.&nbsp;<\/font>N&oacute; cũng được sử dụng để loại bỏ c&aacute;c m&ocirc; giống như nội mạc tử cung bất thường hoặc bị dịch chuyển.&nbsp;<\/font>B&aacute;c sĩ phẫu thuật rạch một đường nhỏ ở bụng để phẫu thuật loại bỏ c&aacute;c khối u ph&aacute;t triển hoặc đốt hoặc l&agrave;m bốc hơi ch&uacute;ng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tLaser hiện nay thường được sử dụng để ph&aacute; hủy m&ocirc; &ldquo;lạc chỗ&rdquo; n&agrave;y.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">Phương ph&aacute;p phẫu thuật cuối c&ugrave;ng (cắt bỏ tử cung)<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\tB&aacute;c sĩ c&oacute; thể đề nghị&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/hysterectomy-side-effects\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">cắt tử cung<\/font><\/font><\/a>&nbsp;to&agrave;n bộ như một biện ph&aacute;p cuối c&ugrave;ng nếu t&igrave;nh trạng của bạn kh&ocirc;ng cải thiện với c&aacute;c phương ph&aacute;p điều trị kh&aacute;c.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tTrong qu&aacute; tr&igrave;nh cắt tử cung to&agrave;n bộ, b&aacute;c sĩ phẫu thuật cắt bỏ tử cung v&agrave; cổ tử cung.&nbsp;<\/font>Họ cũng loại bỏ buồng trứng v&igrave; c&aacute;c cơ quan n&agrave;y tạo ra estrogen v&agrave; estrogen c&oacute; thể g&acirc;y ra sự ph&aacute;t triển của m&ocirc; giống nội mạc tử cung.&nbsp;<\/font>Ngo&agrave;i ra, b&aacute;c sĩ phẫu thuật loại bỏ c&aacute;c tổn thương cấy gh&eacute;p c&oacute; thể nh&igrave;n thấy được.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tHai loại cắt tử cung kh&aacute;c được thực hiện dựa tr&ecirc;n t&igrave;nh trạng của một người đang được điều trị.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMột tổng phụ - c&ograve;n được gọi l&agrave; cắt tử cung b&aacute;n phần hoặc tr&ecirc;n cổ tử cung - loại bỏ phần tr&ecirc;n của tử cung, để lại cổ tử cung tại chỗ.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tCắt bỏ tử cung triệt để thường được thực hiện khi bị ung thư.&nbsp;<\/font>N&oacute; loại bỏ to&agrave;n bộ tử cung, cổ tử cung v&agrave; phần tr&ecirc;n c&ugrave;ng của &acirc;m đạo.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tTrong khi cắt bỏ tử cung c&oacute; thể điều trị lạc nội mạc tử cung th&igrave; n&oacute; kh&ocirc;ng phải l&agrave; c&aacute;ch chữa.&nbsp;<\/font>Bạn sẽ kh&ocirc;ng thể mang thai sau khi cắt bỏ tử cung.&nbsp;<\/font>Nếu bạn đang nghĩ đến việc lập gia đ&igrave;nh, h&atilde;y hỏi &yacute; kiến y tế lần thứ hai trước khi đồng &yacute; phẫu thuật.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\t<a class=\"chartbeat-section\" name=\"causes\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; outline-width:0px; color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:38px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:700; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">Nguy&ecirc;n nh&acirc;n g&acirc;y lạc nội mạc tử cung?<\/font><\/font><\/a>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\tTrong một chu kỳ kinh nguyệt đều đặn, cơ thể bạn sẽ bong ra lớp ni&ecirc;m mạc tử cung.&nbsp;<\/font>Điều n&agrave;y cho ph&eacute;p m&aacute;u kinh nguyệt chảy từ tử cung của bạn qua lỗ nhỏ ở cổ tử cung v&agrave; ra ngo&agrave;i qua &acirc;m đạo.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tNguy&ecirc;n nh&acirc;n ch&iacute;nh x&aacute;c của lạc nội mạc tử cung kh&ocirc;ng được biết.&nbsp;<\/font>C&oacute;<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Governmental authority\" source=\"Office on Women's Health\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.womenshealth.gov\/a-z-topics\/endometriosis\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">một số<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>&nbsp;<a class=\"content-link css-5r4717\" href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/endometriosis\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">l&yacute; thuyết<\/font><\/font><\/a>&nbsp;li&ecirc;n quan đến nguy&ecirc;n nh&acirc;n, mặc d&ugrave; kh&ocirc;ng c&oacute; l&yacute; thuyết n&agrave;o đ&atilde; được chứng minh một c&aacute;ch khoa học.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMột trong những giả thuyết l&acirc;u đời nhất cho rằng lạc nội mạc tử cung xảy ra do một qu&aacute; tr&igrave;nh gọi l&agrave; kinh nguyệt ngược d&ograve;ng,<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Highly respected database from the National Institutes of Health\" source=\"PubMed Central\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3935015\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">90 phần trăm<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>của phụ nữ, theo nghi&ecirc;n cứu.&nbsp;<\/font>Điều n&agrave;y xảy ra khi m&aacute;u kinh chảy ngược qua ống dẫn trứng v&agrave;o khoang chậu của bạn thay v&igrave; ra khỏi cơ thể qua &acirc;m đạo.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMột giả thuyết kh&aacute;c cho rằng hormone biến đổi c&aacute;c tế b&agrave;o b&ecirc;n ngo&agrave;i tử cung th&agrave;nh c&aacute;c tế b&agrave;o tương tự như c&aacute;c tế b&agrave;o l&oacute;t b&ecirc;n trong tử cung, được gọi l&agrave; tế b&agrave;o nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tNhững người kh&aacute;c tin rằng t&igrave;nh trạng n&agrave;y c&oacute; thể xảy ra nếu c&aacute;c v&ugrave;ng nhỏ trong bụng của bạn chuyển đổi th&agrave;nh m&ocirc; giống nội mạc tử cung.&nbsp;<\/font>Điều n&agrave;y c&oacute; thể xảy ra bởi v&igrave; c&aacute;c tế b&agrave;o trong bụng của bạn ph&aacute;t triển từ c&aacute;c tế b&agrave;o ph&ocirc;i, c&oacute; thể thay đổi h&igrave;nh dạng v&agrave; hoạt động giống như c&aacute;c tế b&agrave;o nội mạc tử cung.&nbsp;<\/font>Kh&ocirc;ng biết tại sao điều n&agrave;y xảy ra.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tNhững tế b&agrave;o nội mạc tử cung bị dịch chuyển n&agrave;y c&oacute; thể nằm tr&ecirc;n th&agrave;nh chậu v&agrave; bề mặt của c&aacute;c cơ quan v&ugrave;ng chậu, chẳng hạn như b&agrave;ng quang, buồng trứng v&agrave; trực tr&agrave;ng.&nbsp;<\/font>Ch&uacute;ng tiếp tục ph&aacute;t triển, d&agrave;y l&ecirc;n v&agrave; chảy m&aacute;u trong suốt chu kỳ kinh nguyệt của bạn để đ&aacute;p ứng với c&aacute;c hormone trong chu kỳ của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tCũng c&oacute; thể m&aacute;u kinh bị r&ograve; rỉ v&agrave;o khoang chậu qua vết sẹo phẫu thuật, chẳng hạn như sau khi&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/c-section\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sinh mổ, hay c&ograve;n được gọi l&agrave; sinh mổ<\/font><\/font><\/a>&nbsp;.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\tMột giả thuyết kh&aacute;c cho rằng c&aacute;c tế b&agrave;o nội mạc tử cung được vận chuyển ra ngo&agrave;i tử cung th&ocirc;ng qua hệ thống bạch huyết.&nbsp;<\/font>Vẫn c&ograve;n một giả thuyết kh&aacute;c cho rằng n&oacute; c&oacute; thể l&agrave; do hệ thống miễn dịch hoạt động kh&ocirc;ng hiệu quả trong việc ti&ecirc;u diệt c&aacute;c tế b&agrave;o nội mạc tử cung sai lầm.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMột số người tin rằng lạc nội mạc tử cung c&oacute; thể bắt đầu từ thời kỳ b&agrave;o thai với c&aacute;c m&ocirc; tế b&agrave;o đặt sai vị tr&iacute; bắt đầu phản ứng với c&aacute;c hormone của tuổi dậy th&igrave;.&nbsp;<\/font>Đ&acirc;y thường được gọi l&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15476278.2016.1145317\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">l&yacute; thuyết Mullerian<\/font><\/font><\/a>&nbsp;.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tSự ph&aacute;t triển của lạc nội mạc tử cung cũng c&oacute; thể li&ecirc;n quan đến di truyền hoặc thậm ch&iacute; l&agrave; c&aacute;c chất độc từ m&ocirc;i trường.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\t<a class=\"chartbeat-section\" name=\"stages\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:38px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:700; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">C&aacute;c giai đoạn lạc nội mạc tử cung<\/font><\/font><\/a>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\tLạc nội mạc tử cung c&oacute; bốn giai đoạn hoặc nhiều loại.&nbsp;<\/font>N&oacute; c&oacute; thể l&agrave; bất kỳ điều n&agrave;o sau đ&acirc;y:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">tối thiểu<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">nhạt<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">vừa phải<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">dữ dội<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tC&aacute;c yếu tố kh&aacute;c nhau x&aacute;c định giai đoạn của rối loạn.&nbsp;<\/font>Những yếu tố n&agrave;y c&oacute; thể bao gồm vị tr&iacute;, số lượng, k&iacute;ch thước v&agrave; độ s&acirc;u của cấy gh&eacute;p nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\tGiai đoạn 1: Tối thiểu<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\t<font style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial; vertical-align:inherit\">Trong bệnh lạc nội mạc tử cung tối thiểu, c&oacute; những tổn thương hoặc vết thương nhỏ v&agrave; c&aacute;c m&ocirc; nội mạc tử cung n&ocirc;ng tr&ecirc;n buồng trứng của bạn.&nbsp;<\/font><font style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial; vertical-align:inherit\">Cũng c&oacute; thể bị vi&ecirc;m trong hoặc xung quanh khoang chậu của bạn.<\/font>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Giai đoạn 2: Nhẹ<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tLạc nội mạc tử cung nhẹ bao gồm c&aacute;c tổn thương nhẹ v&agrave; c&aacute;c m&ocirc; n&ocirc;ng tr&ecirc;n buồng trứng v&agrave; ni&ecirc;m mạc v&ugrave;ng chậu.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Giai đoạn 3: Trung b&igrave;nh<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tLạc nội mạc tử cung vừa phải li&ecirc;n quan đến nhiều m&ocirc; cấy s&acirc;u v&agrave;o buồng trứng v&agrave; ni&ecirc;m mạc v&ugrave;ng chậu của bạn.&nbsp;<\/font>Cũng c&oacute; thể c&oacute; nhiều tổn thương hơn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Giai đoạn 4: Nghi&ecirc;m trọng<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tGiai đoạn nghi&ecirc;m trọng nhất của lạc nội mạc tử cung li&ecirc;n quan đến nhiều m&ocirc; cấy s&acirc;u v&agrave;o ni&ecirc;m mạc v&ugrave;ng chậu v&agrave; buồng trứng của bạn.&nbsp;<\/font>Cũng c&oacute; thể c&oacute; những tổn thương tr&ecirc;n ống dẫn trứng v&agrave; ruột của bạn.&nbsp;<\/font>Cũng c&oacute; thể<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Highly respected database from the National Institutes of Health\" source=\"PubMed Central\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559230\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">l&agrave; u nang<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>tr&ecirc;n một hoặc cả hai buồng trứng của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"diagnosis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Chẩn đo&aacute;n<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tC&aacute;c triệu chứng của lạc nội mạc tử cung c&oacute; thể tương tự như c&aacute;c triệu chứng của c&aacute;c bệnh l&yacute; kh&aacute;c, chẳng hạn như u nang buồng trứng v&agrave; bệnh vi&ecirc;m v&ugrave;ng chậu.&nbsp;<\/font>T&igrave;nh trạng n&agrave;y cũng c&oacute; c&aacute;c triệu chứng tương tự với&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/womens-health\/endometriosis-and-ibs#definition\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">hội chứng ruột k&iacute;ch th&iacute;ch (IBS)<\/font><\/font><\/a>&nbsp;, c&oacute; thể k&eacute;o d&agrave;i thời gian chẩn đo&aacute;n.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tCốt l&otilde;i của việc điều trị cơn đau của bạn l&agrave; chẩn đo&aacute;n ch&iacute;nh x&aacute;c.&nbsp;<\/font>Điều quan trọng cần lưu &yacute; l&agrave; qu&aacute; tr&igrave;nh chẩn đo&aacute;n c&oacute; thể kh&aacute;c nhau.&nbsp;<\/font>Trong một số t&igrave;nh huống, c&oacute; thể mất&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.ajog.org\/article\/S0002-9378(19)30002-X\/fulltext\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">từ 4 đến 11 năm kể<\/font><\/font><\/a>&nbsp;từ khi bắt đầu c&oacute; triệu chứng đến khi được chẩn đo&aacute;n, theo nghi&ecirc;n cứu được c&ocirc;ng bố v&agrave;o năm 2019.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tCố gắng ki&ecirc;n nhẫn với bản th&acirc;n v&agrave; qu&aacute; tr&igrave;nh khi bạn l&agrave;m việc với nh&oacute;m chăm s&oacute;c sức khỏe của m&igrave;nh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tB&aacute;c sĩ của bạn sẽ thực hiện một hoặc nhiều x&eacute;t nghiệm sau:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Lịch sử chi tiết<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tB&aacute;c sĩ sẽ lưu &yacute; c&aacute;c triệu chứng v&agrave; tiền sử bệnh nh&acirc;n lạc nội mạc tử cung của bạn.&nbsp;<\/font>Đ&aacute;nh gi&aacute; sức khỏe tổng qu&aacute;t cũng c&oacute; thể được thực hiện để x&aacute;c định xem c&oacute; bất kỳ dấu hiệu n&agrave;o kh&aacute;c của chứng rối loạn k&eacute;o d&agrave;i hay kh&ocirc;ng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Kh&aacute;m sức khỏe<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tTrong khi&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/pelvic-exam\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">kh&aacute;m phụ khoa<\/font><\/font><\/a>&nbsp;, b&aacute;c sĩ sẽ sử dụng mỏ vịt v&agrave; đ&egrave;n chiếu để xem b&ecirc;n trong &acirc;m đạo v&agrave; cổ tử cung.&nbsp;<\/font>Họ cũng sẽ tự sờ bụng của bạn để t&igrave;m u nang hoặc vết sẹo ph&iacute;a sau tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Si&ecirc;u &acirc;m<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tB&aacute;c sĩ c&oacute; thể sử dụng phương&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/transvaginal-ultrasound\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">ph&aacute;p si&ecirc;u &acirc;m qua ng&atilde; &acirc;m đạo<\/font><\/font><\/a>&nbsp;hoặc si&ecirc;u&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/abdominal-ultrasound\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">&acirc;m ổ bụng<\/font><\/font><\/a>&nbsp;.&nbsp;<\/font>Trong si&ecirc;u &acirc;m qua ng&atilde; &acirc;m đạo, một đầu d&ograve; được đưa v&agrave;o &acirc;m đạo của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tCả hai loại si&ecirc;u &acirc;m đều cung cấp h&igrave;nh ảnh về cơ quan sinh sản của bạn.&nbsp;<\/font>Ch&uacute;ng c&oacute; thể gi&uacute;p b&aacute;c sĩ x&aacute;c định u nang li&ecirc;n quan đến lạc nội mạc tử cung, nhưng ch&uacute;ng kh&ocirc;ng hiệu quả trong việc loại trừ căn bệnh n&agrave;y.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Nội soi ổ bụng<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tPhương ph&aacute;p nhất định duy nhất để x&aacute;c định lạc nội mạc tử cung l&agrave; xem trực tiếp.&nbsp;<\/font>Điều n&agrave;y được thực hiện bằng một thủ tục tiểu phẫu được gọi l&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/laparoscopy\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">nội soi ổ bụng<\/font><\/font><\/a>&nbsp;.&nbsp;<\/font>Sau khi được chẩn đo&aacute;n, m&ocirc; c&oacute; thể được loại bỏ trong c&ugrave;ng một quy tr&igrave;nh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"complications\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Biến chứng lạc nội mạc tử cung<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tC&oacute; vấn đề về khả năng sinh sản l&agrave; một biến chứng nghi&ecirc;m trọng của bệnh lạc nội mạc tử cung.&nbsp;<\/font>Những người c&oacute; dạng nhẹ hơn c&oacute; thể c&oacute; thai v&agrave; mang thai đủ th&aacute;ng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMặc d&ugrave; c&oacute; những loại thuốc được sử dụng để điều trị lạc nội mạc tử cung nhưng ch&uacute;ng kh&ocirc;ng gi&uacute;p cải thiện khả năng sinh sản.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMột số người đ&atilde; c&oacute; thể thụ thai sau khi phẫu thuật cắt bỏ m&ocirc; giống nội mạc tử cung.&nbsp;<\/font>Nếu điều n&agrave;y kh&ocirc;ng hiệu quả trong trường hợp của bạn, bạn c&oacute; thể xem x&eacute;t&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/infertility\/doctor-discussion-guide-infertility-treatments\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">c&aacute;c phương ph&aacute;p điều trị sinh sản<\/font><\/font><\/a>&nbsp;hoặc&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/in-vitro-fertilization-ivf\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">thụ tinh trong ống nghiệm<\/font><\/font><\/a>&nbsp;để gi&uacute;p cải thiện cơ hội c&oacute; con.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tN&oacute;i chuyện với b&aacute;c sĩ của bạn để hiểu r&otilde; hơn về c&aacute;c lựa chọn của bạn, chẳng hạn như nếu bạn dự định lập gia đ&igrave;nh v&agrave; liệu bạn c&oacute; n&ecirc;n c&acirc;n nhắc c&oacute; con sớm hơn l&agrave; muộn hơn nếu bạn được chẩn đo&aacute;n mắc bệnh lạc nội mạc tử cung.&nbsp;<\/font>Hoặc b&aacute;c sĩ của bạn c&oacute; thể gi&uacute;p bạn t&igrave;m hiểu th&ecirc;m về c&aacute;c lựa chọn thay thế để trở th&agrave;nh cha mẹ hoặc tr&igrave; ho&atilde;n việc mang thai.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tVới bệnh lạc nội mạc tử cung, c&aacute;c triệu chứng của bạn c&oacute; thể xấu đi theo thời gian, điều n&agrave;y c&oacute; thể g&acirc;y kh&oacute; khăn cho việc thụ thai tự nhi&ecirc;n.&nbsp;<\/font>B&aacute;c sĩ sẽ cần đ&aacute;nh gi&aacute; trước v&agrave; trong khi bạn mang thai.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tNgay cả khi khả năng sinh sản kh&ocirc;ng phải l&agrave; một biến chứng m&agrave; bạn gặp phải, việc kiểm so&aacute;t cơn đau m&atilde;n t&iacute;nh vẫn c&oacute; thể l&agrave; một th&aacute;ch thức.&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/depression\" rel=\"noreferrer noopener\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">Trầm cảm<\/font><\/font><\/a>&nbsp;, lo lắng v&agrave; c&aacute;c vấn đề sức khỏe t&acirc;m thần kh&aacute;c c&oacute; thể ph&aacute;t sinh v&igrave; ch&uacute;ng kh&ocirc;ng hiếm gặp ở những người bị lạc nội mạc tử cung.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tN&oacute;i chuyện với b&aacute;c sĩ của bạn về những c&aacute;ch gi&uacute;p đối ph&oacute; với những t&aacute;c dụng phụ n&agrave;y.&nbsp;<\/font>Họ c&oacute; thể khuy&ecirc;n bạn n&ecirc;n tham gia một nh&oacute;m hỗ trợ hoặc sử dụng c&aacute;c nguồn hỗ trợ kh&aacute;c để gi&uacute;p quản l&yacute; t&igrave;nh huống của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"risk-factors\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">C&aacute;c yếu tố rủi ro<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tLạc nội mạc tử cung thường ph&aacute;t triển nhiều năm sau khi bắt đầu chu kỳ kinh nguyệt của bạn.&nbsp;<\/font>N&oacute; c&oacute; thể l&agrave; một t&igrave;nh trạng đau đớn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tTuy nhi&ecirc;n, hiểu c&aacute;c yếu tố nguy cơ của n&oacute; c&oacute; thể gi&uacute;p bạn x&aacute;c định liệu bạn c&oacute; nhiều khả năng ph&aacute;t triển t&igrave;nh trạng n&agrave;y hơn hay kh&ocirc;ng v&agrave; khi n&agrave;o bạn n&ecirc;n n&oacute;i chuyện với b&aacute;c sĩ của m&igrave;nh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Gi&agrave; đi<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tPhụ nữ ở mọi lứa tuổi đều c&oacute; nguy cơ bị lạc nội mạc tử cung.&nbsp;<\/font>N&oacute; hầu hết<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Governmental authority\" source=\"Office on Women's Health\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.womenshealth.gov\/a-z-topics\/endometriosis\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">thường ảnh hưởng đến phụ nữ<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>ở độ tuổi 30 v&agrave; 40, nhưng c&aacute;c triệu chứng<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Highly respected database from the National Institutes of Health\" source=\"PubMed Central\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3712662\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">c&oacute; thể bắt đầu ở tuổi dậy th&igrave;<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Lịch sử gia đ&igrave;nh<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tN&oacute;i chuyện với b&aacute;c sĩ của bạn nếu bạn c&oacute; một th&agrave;nh vi&ecirc;n trong gia đ&igrave;nh bị lạc nội mạc tử cung.&nbsp;<\/font>Bạn c&oacute; thể c&oacute; nguy cơ ph&aacute;t triển bệnh cao hơn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Tiền sử mang thai<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tMang thai&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"http:\/\/endometriosis.org\/resources\/articles\/myths\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">c&oacute; thể l&agrave;m giảm tạm thời<\/font><\/font><\/a>&nbsp;c&aacute;c triệu chứng của lạc nội mạc tử cung.&nbsp;<\/font>Những phụ nữ chưa c&oacute; con c&oacute; nguy cơ cao mắc chứng rối loạn n&agrave;y.&nbsp;<\/font>Tuy nhi&ecirc;n, lạc nội mạc tử cung vẫn c&oacute; thể xảy ra ở những phụ nữ đ&atilde; từng sinh con.&nbsp;<\/font>Điều n&agrave;y hỗ trợ sự hiểu biết rằng c&aacute;c hormone ảnh hưởng đến sự ph&aacute;t triển v&agrave; tiến triển của t&igrave;nh trạng bệnh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h3 style=\"margin-bottom:20px; margin-top:35px; text-align:start; -webkit-text-stroke-width:0px\">Tiền sử kinh nguyệt<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/h3>\n\n\tN&oacute;i chuyện với b&aacute;c sĩ nếu bạn gặp vấn đề với kỳ kinh nguyệt.&nbsp;<\/font>Những vấn đề n&agrave;y c&oacute; thể bao gồm:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">chu kỳ ngắn hơn<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">nặng hơn v&agrave; thời gian d&agrave;i hơn<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">kinh nguyệt bắt đầu khi c&ograve;n trẻ<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tNhững yếu tố n&agrave;y c&oacute; thể khiến bạn c&oacute; nguy cơ mắc bệnh cao hơn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"race-and-ethnicity-data\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Dữ liệu nghi&ecirc;n cứu về chủng tộc v&agrave; d&acirc;n tộc<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tTrong khi lạc nội mạc tử cung ảnh hưởng đến khoảng<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Governmental authority\" source=\"Office on Women's Health\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.womenshealth.gov\/a-z-topics\/endometriosis#:~:text=How%20common%20is%20endometriosis%3F,the%20United%20States%2C%20have%20endometriosis.\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">11 phần trăm người Mỹ<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>phụ nữ từ 15 đến 44 tuổi, theo Bộ Y tế v&agrave; Dịch vụ Nh&acirc;n sinh Hoa Kỳ, a<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Highly respected database from the National Institutes of Health\" source=\"PubMed Central\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30908874\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">Nghi&ecirc;n cứu năm 2019<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>nhận thấy rằng chủng tộc v&agrave; d&acirc;n tộc c&oacute; thể ảnh hưởng đến sự phổ biến của n&oacute;.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tKhi so s&aacute;nh với phụ nữ da trắng, phụ nữ T&acirc;y Ban Nha v&agrave; Da đen &iacute;t c&oacute; khả năng nhận được chẩn đo&aacute;n lạc nội mạc tử cung hơn.&nbsp;<\/font>Mặt kh&aacute;c, phụ nữ ch&acirc;u &Aacute; c&oacute; khả năng nhận được chẩn đo&aacute;n cao hơn 50% so với phụ nữ da trắng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tTuy nhi&ecirc;n, một<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Peer reviewed journal\" source=\"Wiley\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/1471-0528.15805\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">đ&aacute;nh gi&aacute; được xuất bản v&agrave;o năm 2019<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>ph&aacute;t hiện ra rằng khi kết quả được giới hạn ở phụ nữ v&ocirc; sinh, sự ch&ecirc;nh lệch đối với phụ nữ da đen đ&atilde; giảm xuống;&nbsp;<\/font>kh&ocirc;ng c&oacute; &yacute; nghĩa thống k&ecirc; giữa bệnh nh&acirc;n da đen, da trắng v&agrave; ch&acirc;u &Aacute;.&nbsp;<\/font>C&aacute;c nh&agrave; nghi&ecirc;n cứu lập luận rằng kh&ocirc;ng biết liệu c&aacute;c mối li&ecirc;n hệ trước đ&acirc;y c&oacute; được thực hiện dựa tr&ecirc;n th&agrave;nh kiến chẩn đo&aacute;n hay c&aacute;c yếu tố kh&aacute;c hay kh&ocirc;ng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tNgo&agrave;i ra, c&ograve;n thiếu c&aacute;c nghi&ecirc;n cứu để xem x&eacute;t mức độ phổ biến v&agrave; kết quả ở<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Highly respected database from the National Institutes of Health\" source=\"PubMed Central\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7865200\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">Người Mỹ da đỏ<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>hoặc&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/books.google.com\/books?id=VZdEEAAAQBAJ&amp;pg=PA110&amp;lpg=PA110&amp;dq=Alaskan+Native+people+endometriosis+studies&amp;source=bl&amp;ots=BObN9yNjTe&amp;sig=ACfU3U2ohVsDQYxzc9SqK0dUvY3dx4asmA&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwim2bzwzd_0AhXrSTABHYJ2BfMQ6AF6BAgUEAM#v=onepage&amp;q=Alaskan%20Native%20people%20endometriosis%20studies&amp;f=false\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">phụ nữ thổ d&acirc;n Alaska<\/font><\/font><\/a>&nbsp;.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tNh&igrave;n chung, nghi&ecirc;n cứu to&agrave;n diện hơn về c&aacute;c yếu tố m&ocirc;i trường v&agrave; kinh tế x&atilde; hội v&agrave; khả năng tiếp cận chăm s&oacute;c sức khỏe l&agrave; cần thiết để hiểu r&otilde; hơn về căn bệnh n&agrave;y.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\n\t&nbsp;<\/p>\n\t \n\t \n\t&nbsp;<\/li>\n<\/ul>\n","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/nganh-tam-ly-hoc-3.gif?t=1650436622","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/nganh-tam-ly-hoc-3.gif?t=1788692725","tags":"","count_view":1613,"seo_name":"lac-noi-mac-tu-cung","date_update":1650435214,"date_created_format":1650436629,"meta_title":"","meta_desc":"","meta_keyword":"","qr_code":"https:\/\/psgmedical.com\/lac-noi-mac-tu-cung"},{"id":530280,"name":"Viêm nội mạc tử cung là gì?","desc":"","content":"Vi&ecirc;m nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nVi&ecirc;m nội mạc tử cung l&agrave; t&igrave;nh trạng vi&ecirc;m nhiễm của lớp ni&ecirc;m mạc tử cung v&agrave; thường l&agrave; do nhiễm tr&ugrave;ng.&nbsp;<\/font>N&oacute; thường kh&ocirc;ng nguy hiểm đến t&iacute;nh mạng, nhưng điều quan trọng l&agrave; phải điều trị c&agrave;ng sớm c&agrave;ng tốt.&nbsp;<\/font>N&oacute; thường sẽ biến mất khi được b&aacute;c sĩ điều trị bằng thuốc kh&aacute;ng sinh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nNhiễm tr&ugrave;ng kh&ocirc;ng được điều trị c&oacute; thể dẫn đến c&aacute;c biến chứng với cơ quan sinh sản, c&aacute;c vấn đề về khả năng sinh sản v&agrave; c&aacute;c vấn đề sức khỏe tổng qu&aacute;t kh&aacute;c.&nbsp;<\/font>Để giảm thiểu rủi ro của bạn, h&atilde;y đọc để t&igrave;m hiểu ch&uacute;ng l&agrave; g&igrave;, c&aacute;c triệu chứng v&agrave; triển vọng của bạn nếu được chẩn đo&aacute;n<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n&nbsp;<\/p>\n\n<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"causes\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Nguy&ecirc;n nh&acirc;n của vi&ecirc;m nội mạc tử cung<\/font><\/font><\/a><\/span><\/span><\/div>\n\nVi&ecirc;m nội mạc tử cung n&oacute;i chung l&agrave; do nhiễm tr&ugrave;ng.&nbsp;<\/font>Nhiễm tr&ugrave;ng c&oacute; thể g&acirc;y vi&ecirc;m nội mạc tử cung bao gồm:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;); color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/sexually-transmitted-diseases\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">nhiễm tr&ugrave;ng l&acirc;y truyền qua đường t&igrave;nh dục<\/font><\/font><\/a>&nbsp;(STIs), chẳng hạn như&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/std\/chlamydia\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">chlamydia<\/font><\/font><\/a>&nbsp;v&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/gonorrhea\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">bệnh lậu<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/tuberculosis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">bệnh lao<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">nhiễm tr&ugrave;ng do hỗn hợp vi khuẩn &acirc;m đạo b&igrave;nh thường<\/font><\/font><\/li>\n<\/ul>\n\nTất cả phụ nữ đều c&oacute; một hỗn hợp vi khuẩn b&igrave;nh thường trong &acirc;m đạo của họ.&nbsp;<\/font>Vi&ecirc;m nội mạc tử cung c&oacute; thể được g&acirc;y ra khi hỗn hợp vi khuẩn tự nhi&ecirc;n n&agrave;y thay đổi sau một biến cố trong đời.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"risk-factors\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">C&aacute;c yếu tố nguy cơ của vi&ecirc;m nội mạc tử cung<\/font><\/font><\/a><\/span><\/span><\/div>\n\nBạn c&oacute; nguy cơ bị nhiễm tr&ugrave;ng c&oacute; thể g&acirc;y vi&ecirc;m nội mạc tử cung sau khi sẩy thai hoặc sau khi sinh con, đặc biệt l&agrave; sau khi chuyển dạ l&acirc;u hoặc&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/c-section\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sinh mổ<\/font><\/font><\/a>&nbsp;.&nbsp;<\/font>Bạn cũng c&oacute; nhiều khả năng bị vi&ecirc;m nội mạc tử cung sau một thủ thuật y tế li&ecirc;n quan đến việc x&acirc;m nhập v&agrave;o tử cung qua cổ tử cung.&nbsp;<\/font>Điều n&agrave;y c&oacute; thể tạo đường cho vi khuẩn x&acirc;m nhập.&nbsp;<\/font>C&aacute;c thủ thuật y tế c&oacute; thể l&agrave;m tăng nguy cơ ph&aacute;t triển vi&ecirc;m nội mạc tử cung bao gồm:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;); color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/hysteroscopy\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">soi tử cung<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/birth-control\/iud-infection\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">đặt dụng cụ tử cung (IUD)<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">gi&atilde;n nở v&agrave; nạo (nạo tử cung)<\/font><\/font><\/li>\n<\/ul>\n\nVi&ecirc;m nội mạc tử cung c&oacute; thể xảy ra c&ugrave;ng l&uacute;c với c&aacute;c bệnh l&yacute; kh&aacute;c ở v&ugrave;ng chậu, chẳng hạn như vi&ecirc;m cổ tử cung được gọi l&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/cervicitis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">vi&ecirc;m cổ tử cung<\/font><\/font><\/a>&nbsp;.&nbsp;<\/font>Những t&igrave;nh trạng n&agrave;y c&oacute; thể g&acirc;y ra hoặc kh&ocirc;ng g&acirc;y ra c&aacute;c triệu chứng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"symptoms\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">C&aacute;c triệu chứng của bệnh vi&ecirc;m nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/a><\/span><\/span><\/div>\n\nVi&ecirc;m nội mạc tử cung thường g&acirc;y ra c&aacute;c triệu chứng sau:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<div class=\"css-0\" style=\"text-align:start; -webkit-text-stroke-width:0px\">\n<h2 style=\"margin-bottom:15px; margin-top:45px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"outlook\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Điều g&igrave; c&oacute; thể được mong đợi trong d&agrave;i hạn?<\/font><\/font><\/a><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/div>\n\nTriển vọng đối với những người bị vi&ecirc;m nội mạc tử cung v&agrave; được điều trị kịp thời n&oacute;i chung l&agrave; rất tốt.&nbsp;<\/font>Vi&ecirc;m nội mạc tử cung thường biến mất khi d&ugrave;ng kh&aacute;ng sinh m&agrave; kh&ocirc;ng gặp bất kỳ vấn đề n&agrave;o kh&aacute;c.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nTuy nhi&ecirc;n, c&aacute;c vấn đề về sinh sản v&agrave; nhiễm tr&ugrave;ng nặng c&oacute; thể xảy ra nếu t&igrave;nh trạng n&agrave;y kh&ocirc;ng được điều trị.&nbsp;<\/font>Những điều n&agrave;y c&oacute; thể dẫn đến v&ocirc; sinh hoặc sốc nhiễm tr&ugrave;ng.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<\/div>\n\n<div class=\"css-0\" style=\"text-align:start; -webkit-text-stroke-width:0px\">\n<h2 style=\"margin-bottom:15px; margin-top:45px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"prevention\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">L&agrave;m thế n&agrave;o c&oacute; thể ngăn ngừa vi&ecirc;m nội mạc tử cung?<\/font><\/font><\/a><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/div>\n\nBạn c&oacute; thể giảm nguy cơ bị vi&ecirc;m nội mạc tử cung khi sinh con hoặc một thủ thuật phụ khoa kh&aacute;c bằng c&aacute;ch đảm bảo b&aacute;c sĩ sử dụng thiết bị v&agrave; kỹ thuật v&ocirc; tr&ugrave;ng trong khi sinh hoặc phẫu thuật.&nbsp;<\/font>B&aacute;c sĩ cũng c&oacute; thể sẽ k&ecirc; đơn thuốc kh&aacute;ng sinh để bạn d&ugrave;ng để ph&ograve;ng ngừa khi&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/c-section\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sinh mổ<\/font><\/font><\/a>&nbsp;hoặc ngay trước khi bắt đầu phẫu thuật.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nBạn c&oacute; thể gi&uacute;p giảm nguy cơ vi&ecirc;m nội mạc tử cung do STIs bằng c&aacute;ch:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;)\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/sexually-transmitted-diseases\/safe-sex\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">thực h&agrave;nh t&igrave;nh dục an to&agrave;n<\/font><\/font><\/a>&nbsp;, chẳng hạn như sử dụng bao cao su<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">tầm so&aacute;t định kỳ v&agrave; chẩn đo&aacute;n sớm c&aacute;c bệnh LTQĐTD nghi ngờ ở cả bản th&acirc;n v&agrave; bạn t&igrave;nh của bạn<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">kết th&uacute;c tất cả c&aacute;c điều trị theo quy định cho STI<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n\n<a class=\"css-5r4717 content-link content-link css-30rb2\" data-event=\"In-Content Affiliate Link|undefined|clicked\" data-sponsor-index=\"1\" data-sponsors=\"amzn.to\" href=\"https:\/\/amzn.to\/2pJEJOv?ascsubtag=0d93562d-a52e-4a46-9907-92f75e910b7b&amp;correlationId=0d93562d-a52e-4a46-9907-92f75e910b7b\" rel=\"noopener noreferrer nofollow sponsored\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">Mua sắm trực tuyến cho bao cao su.<\/font><\/font><\/a><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nN&oacute;i chuyện với b&aacute;c sĩ của bạn nếu bạn đang gặp c&aacute;c triệu chứng của vi&ecirc;m nội mạc tử cung.&nbsp;<\/font>Điều quan trọng l&agrave; phải được điều trị để ngăn ngừa bất kỳ biến chứng nghi&ecirc;m trọng n&agrave;o ph&aacute;t sinh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<\/div>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;); color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/abdominal-swelling\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sưng bụng<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">chảy m&aacute;u &acirc;m đạo bất thường<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/vaginal-discharge-color-guide\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">tiết dịch &acirc;m đạo bất thường<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/constipation\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">t&aacute;o b&oacute;n<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">kh&oacute; chịu khi đi ti&ecirc;u<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/fever\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sốt<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/malaise\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">cảm gi&aacute;c ốm yếu<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">đau ở xương chậu, v&ugrave;ng bụng dưới hoặc v&ugrave;ng trực tr&agrave;ng<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"chartbeat-section\" name=\"diagnosis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">L&agrave;m thế n&agrave;o để chẩn đo&aacute;n vi&ecirc;m nội mạc tử cung?<\/font><\/font><\/a><\/span><\/span><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tB&aacute;c sĩ sẽ tiến h&agrave;nh kh&aacute;m sức khỏe tổng thể v&agrave; kh&aacute;m phụ khoa.&nbsp;<\/font>Họ sẽ xem x&eacute;t bụng, tử cung v&agrave; cổ tử cung của bạn để t&igrave;m c&aacute;c dấu hiệu đau v&agrave; tiết dịch.&nbsp;<\/font>C&aacute;c x&eacute;t nghiệm sau cũng c&oacute; thể gi&uacute;p chẩn đo&aacute;n t&igrave;nh trạng bệnh:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">lấy mẫu hoặc nu&ocirc;i cấy từ cổ tử cung để x&eacute;t nghiệm vi khuẩn c&oacute; thể g&acirc;y nhiễm tr&ugrave;ng, chẳng hạn như chlamydia v&agrave; gonococcus (vi khuẩn g&acirc;y bệnh lậu)<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">Loại bỏ một lượng nhỏ m&ocirc; từ ni&ecirc;m mạc tử cung để kiểm tra, được gọi l&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/endometrial-biopsy\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sinh thiết nội mạc tử cung<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">một quy tr&igrave;nh&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/laparoscopy\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">nội soi<\/font><\/font><\/a>&nbsp;cho ph&eacute;p b&aacute;c sĩ của bạn quan s&aacute;t kỹ hơn b&ecirc;n trong bụng hoặc khung chậu của bạn<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">nh&igrave;n v&agrave;o sự ph&oacute;ng điện dưới k&iacute;nh hiển vi<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tX&eacute;t nghiệm m&aacute;u cũng c&oacute; thể được thực hiện để đo số lượng&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/wbc-count\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">bạch cầu (WBC)<\/font><\/font><\/a>&nbsp;v&agrave;&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/esr\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">tốc độ lắng hồng cầu (ESR)<\/font><\/font><\/a>&nbsp;.&nbsp;<\/font>Vi&ecirc;m nội mạc tử cung sẽ l&agrave;m tăng số lượng bạch cầu v&agrave; ESR của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"complications\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">C&aacute;c biến chứng tiềm ẩn của vi&ecirc;m nội mạc tử cung<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tBạn c&oacute; thể gặp c&aacute;c biến chứng v&agrave; thậm ch&iacute; l&agrave; bệnh nặng nếu nhiễm tr&ugrave;ng kh&ocirc;ng được điều trị bằng thuốc kh&aacute;ng sinh.&nbsp;<\/font>C&aacute;c biến chứng c&oacute; thể xảy ra c&oacute; thể ph&aacute;t triển bao gồm:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/infertility\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">kh&ocirc; khan<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/peritonitis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">vi&ecirc;m ph&uacute;c mạc<\/font><\/font><\/a>&nbsp;v&ugrave;ng chậu&nbsp;<\/font>, l&agrave; một bệnh nhiễm tr&ugrave;ng v&ugrave;ng chậu n&oacute;i chung<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">tụ mủ hoặc &aacute;p xe trong khung chậu hoặc tử cung<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tNhiễm tr&ugrave;ng huyết c&oacute; thể g&acirc;y&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/sepsis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">nhiễm tr&ugrave;ng huyết<\/font><\/font><\/a>&nbsp;, đ&acirc;y l&agrave; một bệnh nhiễm tr&ugrave;ng nặng c&oacute; thể trở n&ecirc;n tồi tệ hơn rất nhanh.&nbsp;<\/font>N&oacute; c&oacute; thể dẫn đến sốc nhiễm tr&ugrave;ng, đ&acirc;y l&agrave; một trường hợp khẩn cấp đe dọa t&iacute;nh mạng.&nbsp;<\/font>Cả hai đều cần được điều trị nhanh ch&oacute;ng trong bệnh viện.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tVi&ecirc;m nội mạc tử cung m&atilde;n t&iacute;nh l&agrave; t&igrave;nh trạng nội mạc tử cung bị vi&ecirc;m m&atilde;n t&iacute;nh.&nbsp;<\/font>Một mầm bệnh hiện diện nhưng tạo ra nhiễm tr&ugrave;ng cấp độ thấp v&agrave; hầu hết phụ nữ sẽ kh&ocirc;ng c&oacute; bất kỳ triệu chứng n&agrave;o hoặc c&aacute;c triệu chứng c&oacute; thể bị chẩn đo&aacute;n nhầm.&nbsp;<\/font>Tuy nhi&ecirc;n, vi&ecirc;m nội mạc tử cung m&atilde;n t&iacute;nh đ&atilde;<\/font><\/font><hl-trusted-source class=\"css-12hs4c5\" rationale=\"Highly respected database from the National Institutes of Health\" source=\"PubMed Central\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; display:inline\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5234283\/\" rel=\"noopener noreferrer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\" target=\"_blank\">t&igrave;m<\/font><\/font>Nguồn đ&aacute;ng tin cậy<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/a><\/hl-trusted-source>c&oacute; li&ecirc;n quan đến v&ocirc; sinh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">&nbsp;<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t&nbsp;<\/p>\n\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"treatment\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Điều trị vi&ecirc;m nội mạc tử cung như thế n&agrave;o?<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tVi&ecirc;m nội mạc tử cung được điều trị bằng thuốc kh&aacute;ng sinh.&nbsp;<\/font>Bạn t&igrave;nh của bạn cũng c&oacute; thể cần được điều trị nếu b&aacute;c sĩ ph&aacute;t hiện ra rằng bạn bị STI.&nbsp;<\/font>Điều quan trọng l&agrave; phải uống hết thuốc do b&aacute;c sĩ k&ecirc; đơn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tC&aacute;c trường hợp nghi&ecirc;m trọng hoặc phức tạp c&oacute; thể cần truyền dịch qua&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/intravenous-fluid-regulation\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">đường tĩnh mạch (IV)<\/font><\/font><\/a>&nbsp;v&agrave; nghỉ ngơi tại bệnh viện.&nbsp;<\/font>Điều n&agrave;y đặc biệt đ&uacute;ng nếu t&igrave;nh trạng sau khi sinh con.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t&nbsp;<\/p>\n\t<a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/septicemia\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">nhiễm tr&ugrave;ng huyết<\/font><\/font><\/a>&nbsp;, l&agrave; vi khuẩn trong m&aacute;u<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/septic-shock\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">sốc nhiễm tr&ugrave;ng<\/font><\/font><\/a>&nbsp;, l&agrave; t&igrave;nh trạng nhiễm tr&ugrave;ng m&aacute;u qu&aacute; mức dẫn đến huyết &aacute;p rất thấp<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">&nbsp;<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">&nbsp;<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">&nbsp;<\/li>\n<\/ul>\n","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/Screenshot%202025-09-06%20204729.png","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/Screenshot%202025-09-06%20204729.png","tags":"","count_view":1051,"seo_name":"viem-noi-mac-tu-cung-la-gi","date_update":1650435214,"date_created_format":1650435904,"meta_title":"","meta_desc":"","meta_keyword":"","qr_code":"https:\/\/psgmedical.com\/viem-noi-mac-tu-cung-la-gi"},{"id":530279,"name":"MỤC ĐÍCH CỦA LẤY SINH THIẾT NỘI MẠC TỬ CUNG?","desc":"Sinh thiết nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nSinh thiết nội mạc tử cung l&agrave; việc loại bỏ một phần m&ocirc; nhỏ từ nội mạc tử cung, đ&oacute; l&agrave; lớp ni&ecirc;m mạc của tử cung.&nbsp;<\/font>Mẫu m&ocirc; n&agrave;y c&oacute; thể cho thấy những thay đổi tế b&agrave;o do c&aacute;c m&ocirc; bất thường hoặc sự biến đổi của nồng độ hormone.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nLấy một mẫu nhỏ m&ocirc; nội mạc tử cung gi&uacute;p b&aacute;c sĩ chẩn đo&aacute;n một số t&igrave;nh trạng bệnh l&yacute;.&nbsp;<\/font>Sinh thiết cũng c&oacute; thể kiểm tra nhiễm tr&ugrave;ng tử cung như&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/endometritis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">vi&ecirc;m nội mạc tử cung<\/font><\/font><\/a>&nbsp;.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nSinh thiết nội mạc tử cung c&oacute; thể được thực hiện tại ph&ograve;ng kh&aacute;m của b&aacute;c sĩ m&agrave; kh&ocirc;ng cần sử dụng thuốc g&acirc;y m&ecirc;.&nbsp;<\/font>Th&ocirc;ng thường, thủ tục mất khoảng 10 ph&uacute;t để ho&agrave;n th&agrave;nh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n","content":"Sinh thiết nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nSinh thiết nội mạc tử cung l&agrave; việc loại bỏ một phần m&ocirc; nhỏ từ nội mạc tử cung, đ&oacute; l&agrave; lớp ni&ecirc;m mạc của tử cung.&nbsp;<\/font>Mẫu m&ocirc; n&agrave;y c&oacute; thể cho thấy những thay đổi tế b&agrave;o do c&aacute;c m&ocirc; bất thường hoặc sự biến đổi của nồng độ hormone.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nLấy một mẫu nhỏ m&ocirc; nội mạc tử cung gi&uacute;p b&aacute;c sĩ chẩn đo&aacute;n một số t&igrave;nh trạng bệnh l&yacute;.&nbsp;<\/font>Sinh thiết cũng c&oacute; thể kiểm tra nhiễm tr&ugrave;ng tử cung như&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/endometritis\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">vi&ecirc;m nội mạc tử cung<\/font><\/font><\/a>&nbsp;.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nSinh thiết nội mạc tử cung c&oacute; thể được thực hiện tại ph&ograve;ng kh&aacute;m của b&aacute;c sĩ m&agrave; kh&ocirc;ng cần sử dụng thuốc g&acirc;y m&ecirc;.&nbsp;<\/font>Th&ocirc;ng thường, thủ tục mất khoảng 10 ph&uacute;t để ho&agrave;n th&agrave;nh.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n&nbsp;<\/p>\n\n<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n<div><a class=\"chartbeat-section\" name=\"uses\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Tại sao sinh thiết nội mạc tử cung được thực hiện?<\/font><\/font><\/a><\/span><\/span><\/div>\n\nSinh thiết nội mạc tử cung c&oacute; thể được thực hiện để gi&uacute;p chẩn đo&aacute;n c&aacute;c bất thường của tử cung.&nbsp;<\/font>N&oacute; cũng c&oacute; thể loại trừ c&aacute;c bệnh kh&aacute;c.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\nB&aacute;c sĩ của bạn c&oacute; thể muốn thực hiện sinh thiết nội mạc tử cung để:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;); color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">t&igrave;m nguy&ecirc;n nh&acirc;n g&acirc;y&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/postmenopausal-bleeding\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">chảy m&aacute;u sau m&atilde;n kinh<\/font><\/font><\/a>&nbsp;hoặc&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/dysfunctional-uterine-bleeding\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">chảy m&aacute;u tử cung bất thường<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">tầm so&aacute;t&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/endometrial-cancer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">ung thư nội mạc tử cung<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">đ&aacute;nh gi&aacute; khả năng sinh sản<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">kiểm tra phản ứng của bạn với liệu ph&aacute;p hormone<\/font><\/font><\/li>\n<\/ul>\n\nBạn kh&ocirc;ng thể l&agrave;m sinh thiết nội mạc tử cung khi mang thai v&agrave; bạn cũng kh&ocirc;ng n&ecirc;n l&agrave;m sinh thiết nếu c&oacute; bất kỳ t&igrave;nh trạng n&agrave;o sau đ&acirc;y:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;); color:#231f20; font-family:&quot;Proxima Nova&quot;, &quot;Proxima Nova Fallback&quot;, sans-serif; font-size:18px; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-thickness:initial; text-decoration-style:initial; text-decoration-color:initial\">\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">rối loạn đ&ocirc;ng m&aacute;u<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/pelvic-inflammatory-disease-pid\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#db1f88; outline-width:0px\">bệnh vi&ecirc;m v&ugrave;ng chậu cấp t&iacute;nh<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">nhiễm tr&ugrave;ng cổ tử cung hoặc&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/vaginal-infections\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">&acirc;m đạo cấp t&iacute;nh<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/cervical-cancer\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">ung thư cổ tử cung<\/font><\/font><\/a><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">hẹp cổ tử cung hoặc hẹp cổ tử cung nghi&ecirc;m trọnG<\/font><\/font><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"chartbeat-section\" name=\"preparation\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">L&agrave;m c&aacute;ch n&agrave;o để chuẩn bị cho sinh thiết nội mạc tử cung?<\/font><\/font><\/a><\/span><\/span><\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\tSinh thiết nội mạc tử cung khi mang thai c&oacute; thể dẫn đến sẩy thai.&nbsp;<\/font>H&atilde;y cho b&aacute;c sĩ biết nếu bạn đang mang thai hoặc nếu c&oacute; khả năng bạn c&oacute; thể mang thai.&nbsp;<\/font>B&aacute;c sĩ c&oacute; thể muốn bạn thử thai trước khi sinh thiết để đảm bảo rằng bạn kh&ocirc;ng mang thai.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tB&aacute;c sĩ cũng c&oacute; thể muốn bạn ghi lại c&aacute;c chu kỳ kinh nguyệt trước khi l&agrave;m sinh thiết.&nbsp;<\/font>Điều n&agrave;y thường được y&ecirc;u cầu nếu x&eacute;t nghiệm cần được thực hiện v&agrave;o một thời điểm cụ thể trong chu kỳ của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tN&oacute;i với b&aacute;c sĩ của bạn về bất kỳ loại thuốc k&ecirc; đơn hoặc kh&ocirc;ng k&ecirc; đơn n&agrave;o bạn đang d&ugrave;ng.&nbsp;<\/font>Bạn c&oacute; thể phải ngừng d&ugrave;ng thuốc l&agrave;m lo&atilde;ng m&aacute;u trước khi sinh thiết nội mạc tử cung.&nbsp;<\/font>Những loại thuốc n&agrave;y c&oacute; thể cản trở khả năng đ&ocirc;ng m&aacute;u của m&aacute;u.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tB&aacute;c sĩ c&oacute; thể sẽ muốn biết liệu bạn c&oacute; bị rối loạn chảy m&aacute;u hay kh&ocirc;ng hoặc liệu bạn c&oacute; bị dị ứng với&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/allergies\/latex\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">latex<\/font><\/font><\/a>&nbsp;hoặc&nbsp;<\/font><\/font><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/health\/allergies\/iodine\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">iốt<\/font><\/font><\/a>&nbsp;hay kh&ocirc;ng .<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tSinh thiết nội mạc tử cung c&oacute; thể kh&ocirc;ng thoải m&aacute;i.&nbsp;<\/font>B&aacute;c sĩ c&oacute; thể khuyến nghị bạn d&ugrave;ng ibuprofen (Advil, Motrin) hoặc một loại thuốc giảm đau kh&aacute;c từ 30 đến 60 ph&uacute;t trước khi l&agrave;m thủ thuật.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tB&aacute;c sĩ cũng c&oacute; thể cho bạn uống thuốc an thần nhẹ trước khi l&agrave;m sinh thiết.&nbsp;<\/font>Thuốc an thần c&oacute; thể khiến bạn buồn ngủ, v&igrave; vậy bạn kh&ocirc;ng n&ecirc;n l&aacute;i xe cho đến khi hết t&aacute;c dụng.&nbsp;<\/font>Bạn c&oacute; thể nhờ bạn b&egrave; hoặc th&agrave;nh vi&ecirc;n trong gia đ&igrave;nh chở về nh&agrave; sau khi l&agrave;m thủ tục.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<h2 style=\"margin-bottom:15px; margin-top:45px; text-align:start; -webkit-text-stroke-width:0px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"procedure\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Điều g&igrave; xảy ra khi sinh thiết nội mạc tử cung?<\/font><\/font><\/a><\/span><\/span><\/div>\n\n\tTrước khi l&agrave;m sinh thiết, bạn sẽ được cung cấp &aacute;o cho&agrave;ng hoặc &aacute;o cho&agrave;ng y tế để mặc v&agrave;o.&nbsp;<\/font>Trong ph&ograve;ng kh&aacute;m, b&aacute;c sĩ sẽ y&ecirc;u cầu bạn nằm tr&ecirc;n b&agrave;n, ch&acirc;n c&oacute; kiềng ba ch&acirc;n.&nbsp;<\/font>Sau đ&oacute;, họ l&agrave;m một cuộc kiểm tra nhanh v&ugrave;ng chậu.&nbsp;<\/font>Ch&uacute;ng cũng l&agrave;m sạch &acirc;m đạo v&agrave; cổ tử cung của bạn.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tB&aacute;c sĩ c&oacute; thể đặt một chiếc kẹp v&agrave;o cổ tử cung của bạn để giữ cố định trong qu&aacute; tr&igrave;nh l&agrave;m thủ thuật.&nbsp;<\/font>Bạn c&oacute; thể cảm thấy &aacute;p lực hoặc hơi kh&oacute; chịu từ chiếc kẹp.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tSau đ&oacute;, b&aacute;c sĩ sẽ ch&egrave;n một ống mềm, mỏng được gọi l&agrave; ống dẫn qua lỗ cổ tử cung của bạn, k&eacute;o d&agrave;i th&ecirc;m v&agrave;i inch v&agrave;o tử cung.&nbsp;<\/font>Tiếp theo, họ di chuyển ống h&uacute;t qua lại để lấy mẫu m&ocirc; từ ni&ecirc;m mạc tử cung.&nbsp;<\/font>To&agrave;n bộ quy tr&igrave;nh thường mất khoảng 10 ph&uacute;t.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMẫu m&ocirc; được đưa v&agrave;o chất lỏng v&agrave; gửi đến ph&ograve;ng th&iacute; nghiệm để ph&acirc;n t&iacute;ch.&nbsp;<\/font>B&aacute;c sĩ của bạn sẽ c&oacute; kết quả khoảng 7 đến 10 ng&agrave;y sau khi sinh thiết.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tSau khi l&agrave;m thủ thuật, bạn c&oacute; thể bị ra một &iacute;t đốm nhẹ hoặc chảy m&aacute;u, v&igrave; vậy bạn sẽ được cung cấp một miếng băng kinh nguyệt để đeo.&nbsp;<\/font>Chuột r&uacute;t nhẹ cũng l&agrave; b&igrave;nh thường.&nbsp;<\/font>Bạn c&oacute; thể d&ugrave;ng thuốc giảm đau để giảm chuột r&uacute;t, nhưng nhớ hỏi b&aacute;c sĩ.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tKh&ocirc;ng sử dụng băng vệ sinh hoặc quan hệ t&igrave;nh dục trong v&agrave;i ng&agrave;y sau khi sinh thiết nội mạc tử cung.&nbsp;<\/font>T&ugrave;y thuộc v&agrave;o tiền sử bệnh trước đ&acirc;y của bạn, b&aacute;c sĩ c&oacute; thể cung cấp cho bạn c&aacute;c hướng dẫn bổ sung sau thủ thuật.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\t<\/li>\n\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">\n\t&nbsp;<\/p>\n\n\t<div class=\"css-0\" style=\"text-align:start; -webkit-text-stroke-width:0px\">\n\t<h2 style=\"margin-bottom:15px; margin-top:45px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"risks\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">Những rủi ro li&ecirc;n quan đến sinh thiết nội mạc tử cung l&agrave; g&igrave;?<\/font><\/font><\/a><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/div>\n\n\tGiống như c&aacute;c thủ thuật x&acirc;m lấn kh&aacute;c, c&oacute; một nguy cơ nhiễm tr&ugrave;ng nhỏ.&nbsp;<\/font>Cũng c&oacute; nguy cơ l&agrave;m thủng th&agrave;nh tử cung, nhưng trường hợp n&agrave;y rất hiếm.<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\tMột số chảy m&aacute;u v&agrave; kh&oacute; chịu l&agrave; b&igrave;nh thường.&nbsp;<\/font>Gọi cho b&aacute;c sĩ nếu bạn c&oacute; bất kỳ triệu chứng n&agrave;o sau đ&acirc;y:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;)\">\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">chảy m&aacute;u hơn hai ng&agrave;y sau khi sinh thiết<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">chảy m&aacute;u nhiều<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">sốt hoặc ớn lạnh<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">đau dữ dội ở v&ugrave;ng bụng dưới<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\"><a class=\"content-link css-5r4717\" href=\"https:\/\/www.healthline.com\/symptom\/vaginal-discharge\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; cursor:pointer; text-decoration:none; border-color:currentcolor; color:#02838d\">tiết dịch &acirc;m đạo<\/font><\/a>&nbsp;bất thường hoặc c&oacute; m&ugrave;i bất thường<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t<\/ul>\n\t<\/div>\n\n\t<div class=\"css-0\" style=\"text-align:start; -webkit-text-stroke-width:0px\">\n\t<h2 style=\"margin-bottom:15px; margin-top:45px\">&nbsp;<\/h2>\n\n\t<div><a class=\"chartbeat-section\" name=\"results\" style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit\">những kết quả n&agrave;y c&oacute; nghĩa l&agrave; g&igrave;?<\/font><\/font><\/a><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/div>\n\n\tSinh thiết nội mạc tử cung l&agrave; b&igrave;nh thường khi kh&ocirc;ng t&igrave;m thấy tế b&agrave;o bất thường hoặc ung thư.&nbsp;<\/font>Kết quả được coi l&agrave; bất thường khi:<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n\n\t<ul style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; list-style-image:url(&quot;data:image\/svg+xml,%3Csvg width='10' height='10' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Ccircle cx='5' cy='5' r='2.5' fill='%23EC1C82'\/%3E%3C\/svg%3E&quot;)\">\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">sự ph&aacute;t triển l&agrave;nh t&iacute;nh, hoặc kh&ocirc;ng phải ung thư l&agrave; hiện tại<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">hiện tượng d&agrave;y l&ecirc;n của nội mạc tử cung, được gọi l&agrave; tăng sản nội mạc tử cung<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t\t<li style=\"-webkit-font-smoothing:antialiased; box-sizing:inherit; font-size:18px; line-height:26px; margin-bottom:8px\">tế b&agrave;o ung thư hiện diện<\/font><\/font><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n\t<\/ul>\n\t<\/div>\n\t<\/li>\n<\/ul>\n","image_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/files\/Screenshot%202025-09-06%20143014.png","image_thumb_url":"https:\/\/psgmedical.com\/datafiles\/30494\/upload\/thumb_files\/Screenshot%202025-09-06%20143014.png","tags":"","count_view":913,"seo_name":"sinh-thiet-noi-mac-tu-cung","date_update":1650435214,"date_created_format":1650435541,"meta_title":"","meta_desc":"","meta_keyword":"","qr_code":"https:\/\/psgmedical.com\/sinh-thiet-noi-mac-tu-cung"}]},"widget_15129722":{"content_data":{"content":"NewsLetter"}},"widget_15129726":{"content_data":{"content":"Send<\/span>"}},"widget_15129727":{"content_data":{"content":"About us"}},"widget_15129728":{"content_data":{"content":"PSG MEDICAL VIETNAM has over 6 years of experience in importing medical equipment from advanced countries and Europe. We constantly strive to bring you the highest quality and most advanced medical equipment.<\/p>\n"}},"widget_15129730":{"content_data":{"content":"Contact us"}},"widget_17103321":{"content_data":{"content":"<div class=\"w30s-content\" style=\"height:100%; position:relative\" title=\"Bộ soạn thảo văn bản có định dạng, editor1\">\nHotline: 0765.28.48.68<\/p>\n<\/div>\n"}},"widget_15129734":{"content_data":{"content":"<div class=\"w30s-content\" style=\"height:100%; position:relative\" title=\"Bộ soạn thảo văn bản có định dạng, editor1\">\nĐịa chỉ:<\/p>\n<\/div>\n"}},"widget_15129737":{"content_data":{"content":"<div class=\"w30s-content\" style=\"height:100%; position:relative\" title=\"Bộ soạn thảo văn bản có định dạng, editor1\">\nEmail:<\/p>\n<\/div>\n"}},"widget_15129740":{"content_data":{"content":"<div class=\"w30s-content\" style=\"height:100%; position:relative\" title=\"Bộ soạn thảo văn bản có định dạng, editor1\">\nPhone: 028.6288.3088<\/p>\n<\/div>\n"}},"widget_15129742":{"content_data":{"content":"Our fanpage"}},"widget_15129744":{"content_data":{"content":"Statistics"}},"widget_15129747":{"content_data":{"content":"Social Profiles<\/span>"}},"widget_15129720":{"content_data":{"content":"Thiết kế Website bởi P.A Việt Nam"}}}

Surgical smoke in laparoscopic surgery: Exposure risks and the role of at-source smoke control

Related News

Clinical Evidence - CORAZOR® UROMED Biopsy Device

Why is egg retrieval considered the "key" to the success of the IVF process?

CLINICAL REPORT ON COIL MARKER USING ULTRASOUND GUIDANCE OF VACUUM-ASSISTED BREAST BIOPSY

WHAT IS A VISICOIL FIDUCIAL MARKER?

4 key notes before doing IVF

Notes on choosing an embryo transfer catheter

LẠC NỘI MẠC TỬ CUNG.

Viêm nội mạc tử cung là gì?

MỤC ĐÍCH CỦA LẤY SINH THIẾT NỘI MẠC TỬ CUNG?

NewsLetter

https://psgmedical.com/

About us

Contact us

sale.psgmedical@gmail.com

Our fanpage

Statistics

Social Profiles